{ "instance": { "brhc10035387_20f.htm": { "axisCustom": 0, "axisStandard": 26, "contextCount": 375, "dts": { "calculationLink": { "local": [ "aciu-20211231_cal.xml" ] }, "definitionLink": { "local": [ "aciu-20211231_def.xml" ] }, "inline": { "local": [ "brhc10035387_20f.htm" ] }, "labelLink": { "local": [ "aciu-20211231_lab.xml" ] }, "presentationLink": { "local": [ "aciu-20211231_pre.xml" ] }, "schema": { "local": [ "aciu-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 723, "entityCount": 1, "hidden": { "http://acimume.com/20211231": 8, "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 13, "http://xbrl.sec.gov/dei/2021q4": 5, "total": 26 }, "keyCustom": 127, "keyStandard": 298, "memberCustom": 61, "memberStandard": 40, "nsprefix": "aciu", "nsuri": "http://acimume.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://acimume.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060400 - Disclosure - Property, plant and equipment", "role": "http://acimume.com/role/PropertyPlantAndEquipment", "shortName": "Property, plant and equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinancialAssets", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "092100 - Disclosure - Financial instruments and risk management (Details)", "role": "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "shortName": "Financial instruments and risk management (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:FinancialAssets", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060500 - Disclosure - Right-of-use assets and lease liabilities", "role": "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilities", "shortName": "Right-of-use assets and lease liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060600 - Disclosure - Asset acquisition", "role": "http://acimume.com/role/AssetAcquisition", "shortName": "Asset acquisition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060700 - Disclosure - Intangible assets", "role": "http://acimume.com/role/IntangibleAssets", "shortName": "Intangible assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060800 - Disclosure - Cash and cash equivalents and financial assets", "role": "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssets", "shortName": "Cash and cash equivalents and financial assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060900 - Disclosure - Prepaid expenses and accrued income", "role": "http://acimume.com/role/PrepaidExpensesAndAccruedIncome", "shortName": "Prepaid expenses and accrued income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfPrepaidExpensesAndAccruedIncomeTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfOtherCurrentReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061000 - Disclosure - Other current receivables", "role": "http://acimume.com/role/OtherCurrentReceivables", "shortName": "Other current receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfOtherCurrentReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061100 - Disclosure - Share capital", "role": "http://acimume.com/role/ShareCapital", "shortName": "Share capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061200 - Disclosure - Trade and other payables and accrued expenses", "role": "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpenses", "shortName": "Trade and other payables and accrued expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061300 - Disclosure - Contract revenues", "role": "http://acimume.com/role/ContractRevenues", "shortName": "Contract revenues", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010000 - Statement - Consolidated Balance Sheets", "role": "http://acimume.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:NoncurrentRestrictedCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061400 - Disclosure - Expenses by category", "role": "http://acimume.com/role/ExpensesByCategory", "shortName": "Expenses by category", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfExpensesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061500 - Disclosure - Related-party transactions", "role": "http://acimume.com/role/RelatedpartyTransactions", "shortName": "Related-party transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061600 - Disclosure - Income taxes", "role": "http://acimume.com/role/IncomeTaxes", "shortName": "Income taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061700 - Disclosure - Retirement benefit plan", "role": "http://acimume.com/role/RetirementBenefitPlan", "shortName": "Retirement benefit plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061800 - Disclosure - Share-based compensation", "role": "http://acimume.com/role/SharebasedCompensation", "shortName": "Share-based compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061900 - Disclosure - Commitments and contingencies", "role": "http://acimume.com/role/CommitmentsAndContingencies", "shortName": "Commitments and contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "062000 - Disclosure - Earnings per share", "role": "http://acimume.com/role/EarningsPerShare", "shortName": "Earnings per share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "062100 - Disclosure - Financial instruments and risk management", "role": "http://acimume.com/role/FinancialInstrumentsAndRiskManagement", "shortName": "Financial instruments and risk management", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "062200 - Disclosure - Capital risk management", "role": "http://acimume.com/role/CapitalRiskManagement", "shortName": "Capital risk management", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "062300 - Disclosure - Subsequent events", "role": "http://acimume.com/role/SubsequentEvents", "shortName": "Subsequent events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "020000 - Statement - Consolidated Statements of Income/(Loss)", "role": "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "shortName": "Consolidated Statements of Income/(Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "070300 - Disclosure - Summary of significant accounting policies (Policies)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of significant accounting policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080300 - Disclosure - Summary of significant accounting policies (Tables)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of significant accounting policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080400 - Disclosure - Property, plant and equipment (Tables)", "role": "http://acimume.com/role/PropertyPlantAndEquipmentTables", "shortName": "Property, plant and equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080500 - Disclosure - Right-of-use assets and lease liabilities (Tables)", "role": "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesTables", "shortName": "Right-of-use assets and lease liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080600 - Disclosure - Asset acquisition (Tables)", "role": "http://acimume.com/role/AssetAcquisitionTables", "shortName": "Asset acquisition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080700 - Disclosure - Intangible assets (Tables)", "role": "http://acimume.com/role/IntangibleAssetsTables", "shortName": "Intangible assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080800 - Disclosure - Cash and cash equivalents and financial assets (Tables)", "role": "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsTables", "shortName": "Cash and cash equivalents and financial assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080900 - Disclosure - Prepaid expenses and accrued income (Tables)", "role": "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeTables", "shortName": "Prepaid expenses and accrued income (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081000 - Disclosure - Other current receivables (Tables)", "role": "http://acimume.com/role/OtherCurrentReceivablesTables", "shortName": "Other current receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081100 - Disclosure - Share capital (Tables)", "role": "http://acimume.com/role/ShareCapitalTables", "shortName": "Share capital (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "030000 - Statement - Consolidated Statements of Comprehensive Income/(Loss)", "role": "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "shortName": "Consolidated Statements of Comprehensive Income/(Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081200 - Disclosure - Trade and other payables and accrued expenses (Tables)", "role": "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesTables", "shortName": "Trade and other payables and accrued expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081300 - Disclosure - Contract revenues (Tables)", "role": "http://acimume.com/role/ContractRevenuesTables", "shortName": "Contract revenues (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081400 - Disclosure - Expenses by category (Tables)", "role": "http://acimume.com/role/ExpensesByCategoryTables", "shortName": "Expenses by category (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081500 - Disclosure - Related-party transactions (Tables)", "role": "http://acimume.com/role/RelatedpartyTransactionsTables", "shortName": "Related-party transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081600 - Disclosure - Income taxes (Tables)", "role": "http://acimume.com/role/IncomeTaxesTables", "shortName": "Income taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081700 - Disclosure - Retirement benefit plan (Tables)", "role": "http://acimume.com/role/RetirementBenefitPlanTables", "shortName": "Retirement benefit plan (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081800 - Disclosure - Share-based compensation (Tables)", "role": "http://acimume.com/role/SharebasedCompensationTables", "shortName": "Share-based compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081900 - Disclosure - Commitments and contingencies (Tables)", "role": "http://acimume.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:EarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "082000 - Disclosure - Earnings per share (Tables)", "role": "http://acimume.com/role/EarningsPerShareTables", "shortName": "Earnings per share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:EarningsPerShareExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "082100 - Disclosure - Financial instruments and risk management (Tables)", "role": "http://acimume.com/role/FinancialInstrumentsAndRiskManagementTables", "shortName": "Financial instruments and risk management (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20181231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "040000 - Statement - Consolidated Statements of Changes in Equity", "role": "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "shortName": "Consolidated Statements of Changes in Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20181231_ComponentsOfEquityAxis_RetainedEarningsMember", "decimals": "-3", "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:NumberOfTechnologyPlatforms", "reportCount": 1, "unique": true, "unitRef": "U004", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090100 - Disclosure - General information (Details)", "role": "http://acimume.com/role/GeneralInformationDetails", "shortName": "General information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:NumberOfTechnologyPlatforms", "reportCount": 1, "unique": true, "unitRef": "U004", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090200 - Disclosure - Basis of preparation (Details)", "role": "http://acimume.com/role/BasisOfPreparationDetails", "shortName": "Basis of preparation (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "3", "first": true, "lang": null, "name": "ifrs-full:ClosingForeignExchangeRate", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090300 - Disclosure - Summary of significant accounting policies, Functional and reporting currency (Details)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails", "shortName": "Summary of significant accounting policies, Functional and reporting currency (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "3", "lang": null, "name": "ifrs-full:AverageForeignExchangeRate", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:EstimatedLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090302 - Disclosure - Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails", "shortName": "Summary of significant accounting policies, Right-of-use assets and lease liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ClassesOfPropertyPlantAndEquipmentAxis_BuildingsMember", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:EstimatedLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090304 - Disclosure - Summary of significant accounting policies, Property, plant and equipment (Details)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails", "shortName": "Summary of significant accounting policies, Property, plant and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ClassesOfPropertyPlantAndEquipmentAxis_ComputerEquipmentMember", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:IncomeTaxLossCarryforwardPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090306 - Disclosure - Summary of significant accounting policies, Income taxes (Details)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails", "shortName": "Summary of significant accounting policies, Income taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:IncomeTaxLossCarryforwardPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:OperatingSegmentsNumber", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090308 - Disclosure - Summary of significant accounting policies, Segment reporting (Details)", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails", "shortName": "Summary of significant accounting policies, Segment reporting (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:OperatingSegmentsNumber", "reportCount": 1, "unique": true, "unitRef": "U005", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:PropertyPlantAndEquipment", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090400 - Disclosure - Property, plant and equipment (Details)", "role": "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "shortName": "Property, plant and equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_GrossCarryingAmountMember", "decimals": "-3", "lang": null, "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090500 - Disclosure - Right-of-use assets and lease liabilities (Details)", "role": "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "shortName": "Right-of-use assets and lease liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20191231", "decimals": "-3", "lang": null, "name": "ifrs-full:RightofuseAssets", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_BusinessCombinationsAxis_AffirisAGMember", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfInstrumentsOrInterestsIssuedOrIssuable", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090600 - Disclosure - Asset acquisition (Details)", "role": "http://acimume.com/role/AssetAcquisitionDetails", "shortName": "Asset acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_BusinessCombinationsAxis_AffirisAGMember", "decimals": "-5", "lang": null, "name": "ifrs-full:CashTransferred", "reportCount": 1, "unique": true, "unitRef": "U007", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "050000 - Statement - Consolidated Statements of Cash Flows", "role": "http://acimume.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:AdjustmentsForDepreciationExpense", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090700 - Disclosure - Intangible assets, Carrying amount and net book value (Details)", "role": "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails", "shortName": "Intangible assets, Carrying amount and net book value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090800 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)", "role": "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails", "shortName": "Cash and cash equivalents and financial assets, Cash and cash equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_CurrencyAxis_CHF", "decimals": "-3", "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentFinancialAssets", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090802 - Disclosure - Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)", "role": "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShorttermFinancialAssetsDetails", "shortName": "Cash and cash equivalents and financial assets, Cash and cash equivalents and short-term financial assets (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R63": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentPrepayments", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090900 - Disclosure - Prepaid expenses and accrued income (Details)", "role": "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails", "shortName": "Prepaid expenses and accrued income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "aciu:DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:OtherCurrentReceivables", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091000 - Disclosure - Other current receivables (Details)", "role": "http://acimume.com/role/OtherCurrentReceivablesDetails", "shortName": "Other current receivables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "aciu:DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:OtherCurrentReceivables", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091100 - Disclosure - Share capital, Capital Structure (Details)", "role": "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "shortName": "Share capital, Capital Structure (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "0", "lang": null, "name": "aciu:NumberOfOtherEquityInstrumentsExpiredOrForfeitedInShareBasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_ClassesOfShareCapitalAxis_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:ParValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091102 - Disclosure - Share capital, Conditional Share Capital for Bonds and Similar Debt Instruments (Details)", "role": "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "shortName": "Share capital, Conditional Share Capital for Bonds and Similar Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_ClassesOfShareCapitalAxis_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:ParValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_ClassesOfShareCapitalAxis_ConditionalShareCapitalForEmployeeBenefitPlansMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:ParValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091104 - Disclosure - Share capital, Conditional Share Capital for Employee Benefit Plans (Details)", "role": "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "shortName": "Share capital, Conditional Share Capital for Employee Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_ClassesOfShareCapitalAxis_ConditionalShareCapitalForEmployeeBenefitPlansMember", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:ParValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210428", "decimals": "0", "first": true, "lang": null, "name": "aciu:ShelfRegistrationStatementSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091106 - Disclosure - Share capital, Shelf Registration Statement (Details)", "role": "http://acimume.com/role/ShareCapitalShelfRegistrationStatementDetails", "shortName": "Share capital, Shelf Registration Statement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210428", "decimals": "0", "first": true, "lang": null, "name": "aciu:ShelfRegistrationStatementSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProceedsFromSaleOrIssueOfTreasuryShares", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091108 - Disclosure - Share capital, At the Market Equity Offering (Details)", "role": "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "shortName": "Share capital, At the Market Equity Offering (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200930_ClassesOfShareCapitalAxis_AtTheMarketEquityOfferingMember", "decimals": "0", "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060100 - Disclosure - General information", "role": "http://acimume.com/role/GeneralInformation", "shortName": "General information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "aciu:DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "aciu:ProceedsFromIssueOfConvertibleDebt", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091110 - Disclosure - Share capital, Convertible Note Agreement (Details)", "role": "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails", "shortName": "Share capital, Convertible Note Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_ClassesOfShareCapitalAxis_ConvertibleNoteAgreementMember", "decimals": "-5", "lang": null, "name": "aciu:ConvertibleBorrowings", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:TradeAndOtherCurrentPayables", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091200 - Disclosure - Trade and other payables and accrued expenses (Details)", "role": "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails", "shortName": "Trade and other payables and accrued expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "aciu:DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "lang": null, "name": "aciu:CurrentAccruedResearchAndDevelopmentCosts", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091300 - Disclosure - Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)", "role": "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "shortName": "Contract revenues, Contract Revenue Attributable to Licensing Arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-5", "lang": null, "name": "aciu:RevenueReclassifiedToOtherIncomeExpense", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CurrentContractAssets", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091302 - Disclosure - Contract revenues, Changes in Contract Assets and Liabilities (Details)", "role": "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails", "shortName": "Contract revenues, Changes in Contract Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "lang": null, "name": "aciu:ContractAssetsAdditions", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091304 - Disclosure - Contract revenues, Recognized Revenues (Details)", "role": "http://acimume.com/role/ContractRevenuesRecognizedRevenuesDetails", "shortName": "Contract revenues, Recognized Revenues (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091306 - Disclosure - Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)", "role": "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "shortName": "Contract revenues, Morphomer Tau small molecule - 2018 license agreement with Eli Lilly and Company (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ProductsAndServicesAxis_TauMorphomerSmallMoleculeMember_TypesOfContractsAxis_CollaborationAgreementWithLillyMember", "decimals": "-6", "lang": null, "name": "aciu:CollaborativeAgreementMilestonePaymentReceived", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091308 - Disclosure - Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)", "role": "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "shortName": "Contract revenues, Anti-Abeta Antibody in AD - 2006 Agreement with Genentech (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_ProductsAndServicesAxis_AntiAbetaAntibodyInADMember_TypesOfContractsAxis_CollaborationAgreementOf2006GenentechMember", "decimals": "-5", "lang": null, "name": "aciu:CollaborativeAgreementCumulativePaymentsReceived", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091310 - Disclosure - Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)", "role": "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "shortName": "Contract revenues, Anti-Tau Antibody in AD - 2012 Agreement with Genentech (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ProductsAndServicesAxis_AntiTauAntibodyInADMember_TypesOfContractsAxis_CollaborationAgreementOf2012GenentechMember", "decimals": null, "lang": "en-US", "name": "aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091312 - Disclosure - Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)", "role": "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "shortName": "Contract revenues, Tau Vaccine in AD - 2014 Agreement with Janssen Pharmaceuticals (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ProductsAndServicesAxis_TauVaccineInADMember_TypesOfContractsAxis_CollaborationAgreementOf2014JanssenPharmaceuticalsMember", "decimals": null, "lang": "en-US", "name": "aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091314 - Disclosure - Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)", "role": "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails", "shortName": "Contract revenues, Tau-PET imaging agent -2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ProductsAndServicesAxis_TauPETImagingAgentMember_TypesOfContractsAxis_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember", "decimals": null, "lang": "en-US", "name": "aciu:CollaborativeAgreementNoticeOfContractTerminationPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060200 - Disclosure - Basis of preparation", "role": "http://acimume.com/role/BasisOfPreparation", "shortName": "Basis of preparation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091316 - Disclosure - Contract revenues, A-syn and TDP-43 PET tracers - 2016 agreement with Biogen (Details)", "role": "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "shortName": "Contract revenues, A-syn and TDP-43 PET tracers - 2016 agreement with Biogen (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_ProductsAndServicesAxis_AlphaSynucleinAndTDP43PETTracerInADMember_TypesOfContractsAxis_CollaborationAgreementOf2016BiogenMember", "decimals": "INF", "lang": null, "name": "aciu:NumberOfPerformanceObligationsIdentified", "reportCount": 1, "unique": true, "unitRef": "U016", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091318 - Disclosure - Contract revenues, Grants from the Michael J. Fox Foundation (Details)", "role": "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "shortName": "Contract revenues, Grants from the Michael J. Fox Foundation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_TypesOfContractsAxis_GrantsMichaelJFoxFoundationMember", "decimals": "INF", "lang": null, "name": "aciu:NumberOfGrants", "reportCount": 1, "unique": true, "unitRef": "U017", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20200101to20201231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:RevenueFromContractsWithCustomers", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091322 - Disclosure - Contract revenues, Grant from the Target ALS Foundation (Details)", "role": "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "shortName": "Contract revenues, Grant from the Target ALS Foundation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210331_TypesOfContractsAxis_GrantFromTargetALSFoundationMember", "decimals": "-5", "lang": null, "name": "aciu:CollaborativeAgreementPotentialValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "aciu:ResearchAndDevelopmentExpenseAllocationOperatingExpense", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091400 - Disclosure - Expenses by category (Details)", "role": "http://acimume.com/role/ExpensesByCategoryDetails", "shortName": "Expenses by category (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "aciu:ResearchAndDevelopmentExpenseAllocationOperatingExpense", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "div", "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:NumberOfPersonsKeyManagementBoardOfDirectors", "reportCount": 1, "unique": true, "unitRef": "U020", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091500 - Disclosure - Related-party transactions (Details)", "role": "http://acimume.com/role/RelatedpartyTransactionsDetails", "shortName": "Related-party transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:NumberOfPersonsKeyManagementBoardOfDirectors", "reportCount": 1, "unique": true, "unitRef": "U020", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:IncomeTaxExpenseContinuingOperations", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091600 - Disclosure - Income taxes, Summary of Income Tax Expense (Details)", "role": "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "shortName": "Income taxes, Summary of Income Tax Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ifrs-full:DeferredTaxLiabilities", "ifrs-full:DeferredTaxLiabilities", "ifrs-full:DeferredTaxAssets", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:DeferredTaxLiabilities", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DeferredTaxAssets", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091602 - Disclosure - Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)", "role": "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "shortName": "Income taxes, Unrecognized Deductible Temporary Differences, Unused Tax Losses and Unused Tax Credits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-3", "lang": null, "name": "ifrs-full:DeferredTaxLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_NetDefinedBenefitLiabilityAssetAxis_PresentValueOfDefinedBenefitObligationMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091700 - Disclosure - Retirement benefit plan, Summary of Benefit Plan (Details)", "role": "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails", "shortName": "Retirement benefit plan, Summary of Benefit Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_NetDefinedBenefitLiabilityAssetAxis_PresentValueOfDefinedBenefitObligationMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:DefinedBenefitObligationAtPresentValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091702 - Disclosure - Retirement benefit plan, Changes in Defined Benefit Obligation (Details)", "role": "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "shortName": "Retirement benefit plan, Changes in Defined Benefit Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20181231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember_NetDefinedBenefitLiabilityAssetAxis_PresentValueOfDefinedBenefitObligationMember", "decimals": "-3", "lang": null, "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "-3", "first": true, "lang": null, "name": "aciu:InterestIncomeNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091704 - Disclosure - Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)", "role": "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "shortName": "Retirement benefit plan, Changes in Fair Value of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20181231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember_NetDefinedBenefitLiabilityAssetAxis_PlanAssetsMember", "decimals": "-3", "lang": null, "name": "ifrs-full:PlanAssetsAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060300 - Disclosure - Summary of significant accounting policies", "role": "http://acimume.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of significant accounting policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091706 - Disclosure - Retirement benefit plan, Change in Net Defined Benefit Liability (Details)", "role": "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "shortName": "Retirement benefit plan, Change in Net Defined Benefit Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "-3", "lang": null, "name": "ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091708 - Disclosure - Retirement benefit plan, Change in Other Comprehensive Loss (Details)", "role": "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "shortName": "Retirement benefit plan, Change in Other Comprehensive Loss (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "-3", "lang": null, "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091710 - Disclosure - Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)", "role": "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails", "shortName": "Retirement benefit plan, Actuarial Assumptions and Sensitivity Analysis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231_DefinedBenefitPlansAxis_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "decimals": "4", "first": true, "lang": null, "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:NumberOfEquityBasedInstrumentPlans", "reportCount": 1, "unique": true, "unitRef": "U021", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091800 - Disclosure - Share-based compensation, Plans Outstanding (Details)", "role": "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails", "shortName": "Share-based compensation, Plans Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "INF", "first": true, "lang": null, "name": "aciu:NumberOfEquityBasedInstrumentPlans", "reportCount": 1, "unique": true, "unitRef": "U021", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20201231", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091802 - Disclosure - Share-based compensation, Weighted Average Exercise Prices (Details)", "role": "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails", "shortName": "Share-based compensation, Weighted Average Exercise Prices (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20181231", "decimals": "2", "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091804 - Disclosure - Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)", "role": "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "shortName": "Share-based compensation, Outstanding Options, Range of Exercise prices and Expiration Dates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "2", "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019", "reportCount": 1, "unique": true, "unitRef": "U023", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091806 - Disclosure - Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)", "role": "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails", "shortName": "Share-based compensation, Weighted Average Grant date Fair Value and Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "2", "first": true, "lang": null, "name": "ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019", "reportCount": 1, "unique": true, "unitRef": "U023", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "reportCount": 1, "unitRef": "U003", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091808 - Disclosure - Share-based compensation, Non-vested Share Awards (Details)", "role": "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "shortName": "Share-based compensation, Non-vested Share Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "2", "lang": null, "name": "aciu:WeightedAverageExercisePriceOfNonVestedOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-5", "first": true, "lang": null, "name": "aciu:ProvisionsResearchContracts", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "091900 - Disclosure - Commitments and contingencies (Details)", "role": "http://acimume.com/role/CommitmentsAndContingenciesDetails", "shortName": "Commitments and contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20211231", "decimals": "-5", "first": true, "lang": null, "name": "aciu:ProvisionsResearchContracts", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "092000 - Disclosure - Earnings per share (Details)", "role": "http://acimume.com/role/EarningsPerShareDetails", "shortName": "Earnings per share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "ifrs-full:EarningsPerShareExplanatory", "div", "div", "body", "html" ], "baseRef": "brhc10035387_20f.htm", "contextRef": "c20210101to20211231", "decimals": "0", "lang": null, "name": "ifrs-full:WeightedAverageShares", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } } }, "segmentCount": 105, "tag": { "aciu_AccruedExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for accrued expenses.", "label": "Accrued Expenses [Member]" } } }, "localname": "AccruedExpensesMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_AccruedStampDuty": { "auth_ref": [], "calculation": { "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails": { "order": 3.0, "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of current accrued stamp duty.", "label": "Accrued stamp duty", "terseLabel": "Accrued stamp duty" } } }, "localname": "AccruedStampDuty", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_AdjustmentsForDecreaseIncreaseInAccruedIncome": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in accrued income to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]", "label": "Adjustments for decrease (increase) in accrued income", "terseLabel": "Decrease /(increase) in accrued income" } } }, "localname": "AdjustmentsForDecreaseIncreaseInAccruedIncome", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_AdjustmentsForDecreaseIncreaseInPrepaidExpense": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for decrease (increase) in prepaid expense", "negatedLabel": "Decrease/(increase) in prepaid expenses" } } }, "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpense", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_AdjustmentsForDepreciationExpenseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for depreciation expense, right-of-use assets", "terseLabel": "Depreciation of right-of-use assets" } } }, "localname": "AdjustmentsForDepreciationExpenseRightOfUseAssets", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_AdjustmentsForIncreaseDecreaseInAccruedExpenses": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for increase (decrease) in accrued expenses", "negatedLabel": "Increase /(decrease) in accrued expenses" } } }, "localname": "AdjustmentsForIncreaseDecreaseInAccruedExpenses", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_AffirisAGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the acquired entity.", "label": "Affiris AG [Member]" } } }, "localname": "AffirisAGMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "domainItemType" }, "aciu_AlphaSynucleinAndTDP43PETTracerInADMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The research and development of medicines for the treatment of Alzheimer's disease.", "label": "Alpha-synuclein and TDP-43 PET tracer in AD [Member]", "verboseLabel": "A-syn and TDP-43 PET Tracers [Member]" } } }, "localname": "AlphaSynucleinAndTDP43PETTracerInADMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails" ], "xbrltype": "domainItemType" }, "aciu_AntiAbetaAntibodyInADMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The research and development of medicines for the treatment of Alzheimer's disease.", "label": "Anti-Abeta antibody in AD [Member]", "terseLabel": "Anti-Abeta Antibody in AD [Member]" } } }, "localname": "AntiAbetaAntibodyInADMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails" ], "xbrltype": "domainItemType" }, "aciu_AntiTauAntibodyInADMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The research and development of medicines for the treatment of Alzheimer's disease.", "label": "Anti-tau antibody in AD [Member]", "terseLabel": "Anti-tau Antibody in AD [Member]" } } }, "localname": "AntiTauAntibodyInADMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails" ], "xbrltype": "domainItemType" }, "aciu_AntidilutiveSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive securities [Abstract]" } } }, "localname": "AntidilutiveSecuritiesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "aciu_AssetAcquisitionDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset acquisition, Disclosure [Abstract]", "terseLabel": "Asset acquisition [Abstract]" } } }, "localname": "AssetAcquisitionDisclosureAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "aciu_AtTheMarketEquityOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "At the Market Equity Offering [Abstract]", "terseLabel": "At the Market Equity Offering [Abstract]" } } }, "localname": "AtTheMarketEquityOfferingAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "stringItemType" }, "aciu_AtTheMarketEquityOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An \"at-the-market\" offering is an offering of securities into an existing trading market for outstanding shares of the same class at other than a fixed price on, or through the facilities of, a national securities exchange, or to or through a market maker otherwise than on an exchange.", "label": "At the Market Equity Offering [Member]", "terseLabel": "At the Market Equity Offering [Member]" } } }, "localname": "AtTheMarketEquityOfferingMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "domainItemType" }, "aciu_AthosServiceGmbHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder of Affiris.", "label": "Athos Service GmbH [Member]", "terseLabel": "Athos Service GmbH [Member]" } } }, "localname": "AthosServiceGmbHMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "domainItemType" }, "aciu_BasisOfPreparationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of preparation [Abstract]" } } }, "localname": "BasisOfPreparationAbstract", "nsuri": "http://acimume.com/20211231", "xbrltype": "stringItemType" }, "aciu_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Key managers of an entity who collectively have responsibility of governing the entity.", "label": "Board of Directors [Member]", "verboseLabel": "Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "domainItemType" }, "aciu_BorrowingsDebtExtinguishmentPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The expected period over which a debt obligation is expected to be extinguished in full, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Borrowings, debt extinguishment period", "terseLabel": "Expected debt obligation payoff period" } } }, "localname": "BorrowingsDebtExtinguishmentPeriod", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "durationItemType" }, "aciu_CashAdvancesForRentDeposit": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for deposit of rent.", "label": "Cash Advances for Rent Deposit", "negatedLabel": "Rental deposits" } } }, "localname": "CashAdvancesForRentDeposit", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_CashAndCashEquivalentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Cash and cash equivalent [Line Items]" } } }, "localname": "CashAndCashEquivalentLineItems", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "aciu_CashAndCashEquivalentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash and cash equivalent balances, including foreign currencies in which the balances are denominated.", "label": "Cash and cash equivalents [Table]" } } }, "localname": "CashAndCashEquivalentsTable", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "aciu_CashOnHandAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.", "label": "Cash on hand and cash equivalents [Member]", "terseLabel": "Cash and Cash Equivalents [Member]" } } }, "localname": "CashOnHandAndCashEquivalentsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_ChangesInFairValueOfPlanAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in fair value of plan assets [Abstract]", "terseLabel": "Changes in fair value of plan assets [Abstract]" } } }, "localname": "ChangesInFairValueOfPlanAssetsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "aciu_ChangesInWorkingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in working capital [Abstract]", "terseLabel": "Changes in working capital:" } } }, "localname": "ChangesInWorkingCapitalAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "aciu_ClosingForeignExchangeRateDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage decrease to spot exchange rate at the end of the reporting period.", "label": "Closing foreign exchange rate, decrease", "terseLabel": "Percentage exchange rate weakened" } } }, "localname": "ClosingForeignExchangeRateDecrease", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "percentItemType" }, "aciu_ClosingForeignExchangeRateIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage increase to spot exchange rate at the end of the reporting period.", "label": "Closing foreign exchange rate, increase", "terseLabel": "Percentage exchange rate strengthened" } } }, "localname": "ClosingForeignExchangeRateIncrease", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "percentItemType" }, "aciu_CollaborationAgreementOf2006GenentechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2006 contractual research agreement associated with collaboration with Genentech.", "label": "Collaboration agreement of 2006, Genentech [Member]", "verboseLabel": "2006 Agreement with Genentech [Member]" } } }, "localname": "CollaborationAgreementOf2006GenentechMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAgreementOf2012GenentechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2012 contractual research agreement associated with collaboration with Genentech.", "label": "Collaboration agreement of 2012, Genentech [Member]", "terseLabel": "2012 Agreement with Genentech [Member]", "verboseLabel": "Genentech [Member]" } } }, "localname": "CollaborationAgreementOf2012GenentechMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAgreementOf2014JanssenPharmaceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2014 contractual research agreement associated with collaboration with Janssen Pharmaceuticals.", "label": "Collaboration agreement of 2014, Janssen Pharmaceuticals [Member]", "terseLabel": "2014 Agreement with Janssen Pharmaceuticals [Member]", "verboseLabel": "Janssen [Member]" } } }, "localname": "CollaborationAgreementOf2014JanssenPharmaceuticalsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails", "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAgreementOf2016BiogenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2016 contractual research agreement associated with collaboration with Biogen.", "label": "Collaboration agreement of 2016, Biogen [Member]", "terseLabel": "2016 Agreement with Biogen [Member]", "verboseLabel": "Biogen [Member]" } } }, "localname": "CollaborationAgreementOf2016BiogenMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAgreementWithLillyFirstAmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The first amendment to the collaboration agreement with Lilly for research and development.", "label": "Collaboration Agreement with Lilly, First Amendment [Member]", "terseLabel": "2018 License Agreement with Eli Lilly, First Amendment [Member]" } } }, "localname": "CollaborationAgreementWithLillyFirstAmendmentMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAgreementWithLillyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The collaboration agreement with Lilly for research and development.", "label": "Collaboration Agreement with Lilly [Member]", "terseLabel": "Lilly [Member]", "verboseLabel": "2018 License Agreement with Eli Lilly and Company [Member]" } } }, "localname": "CollaborationAgreementWithLillyMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAgreementWithLillySecondAmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The second amendment to the collaboration agreement with Lilly for research and development.", "label": "Collaboration Agreement with Lilly, Second Amendment [Member]", "terseLabel": "2018 License Agreement with Eli Lilly, Second Amendment [Member]" } } }, "localname": "CollaborationAgreementWithLillySecondAmendmentMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborationAndLicenseRevenueAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.", "label": "Collaboration and License Revenue Agreements [Member]", "terseLabel": "Collaboration and License Revenue [Member]", "verboseLabel": "Collaboration and License Revenue Agreements [Member]" } } }, "localname": "CollaborationAndLicenseRevenueAgreementsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "domainItemType" }, "aciu_CollaborativeAgreementCollaborationContractReceivableForClinicalMilestones": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount that the entity is eligible to receive for clinical milestones from a collaborative agreement..", "label": "Collaborative agreement, Collaboration contract receivable for clinical milestones", "terseLabel": "Collaboration contract receivable for clinical milestones" } } }, "localname": "CollaborativeAgreementCollaborationContractReceivableForClinicalMilestones", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CollaborativeAgreementCollaborationContractReceivableForRegulatoryCommercializationAndSalesMilestones": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount that the entity is eligible to receive for regulatory, commercialization and sales milestones from a collaborative agreement.", "label": "Collaborative agreement, Collaboration contract receivable for regulatory, commercialization and sales milestones", "terseLabel": "Collaboration contract receivable for regulatory, commercialization and sales milestones" } } }, "localname": "CollaborativeAgreementCollaborationContractReceivableForRegulatoryCommercializationAndSalesMilestones", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CollaborativeAgreementCumulativePaymentsReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative payments received related to revenue from upfront license fees, milestone payments and revenue from research agreements associated with a collaborative agreement.", "label": "Collaborative agreement, Cumulative payments received", "verboseLabel": "Cumulative payments received" } } }, "localname": "CollaborativeAgreementCumulativePaymentsReceived", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CollaborativeAgreementJointResearchCollaborationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period over which collaborating entities are contracted to perform research, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Collaborative agreement, Joint research collaboration period", "terseLabel": "Period of joint research agreement" } } }, "localname": "CollaborativeAgreementJointResearchCollaborationPeriod", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails" ], "xbrltype": "durationItemType" }, "aciu_CollaborativeAgreementMilestonePaymentNumberOfInstallments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of installments for satisfying a milestone payment associated with a collaborative agreement.", "label": "Collaborative agreement, milestone payment, number of installments", "terseLabel": "Number of installments" } } }, "localname": "CollaborativeAgreementMilestonePaymentNumberOfInstallments", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "integerItemType" }, "aciu_CollaborativeAgreementMilestonePaymentReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment(s) received for milestone payments associated with a collaborative agreement.", "label": "Collaborative agreement, Milestone payment received", "terseLabel": "Milestone payment received" } } }, "localname": "CollaborativeAgreementMilestonePaymentReceived", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CollaborativeAgreementMilestonePaymentRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of consideration recognized for the milestone payment(s) associated with a collaborative agreement during the period.", "label": "Collaborative Agreement, Milestone Payment Recognized", "terseLabel": "Milestone payment recognized" } } }, "localname": "CollaborativeAgreementMilestonePaymentRecognized", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CollaborativeAgreementNoticeOfContractTerminationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Collaborative agreement, Notice of contract termination period", "terseLabel": "Period to provide notice of termination of agreement" } } }, "localname": "CollaborativeAgreementNoticeOfContractTerminationPeriod", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "durationItemType" }, "aciu_CollaborativeAgreementPotentialValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total potential value of the collaborative agreement.", "label": "Collaborative agreement, potential value", "terseLabel": "Total potential collaboration agreement value" } } }, "localname": "CollaborativeAgreementPotentialValue", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CommissionsPaidForIssuanceOrdinaryShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of commissions paid for issuance ordinary shares.", "label": "Commissions paid for issuance ordinary shares", "terseLabel": "Commissions paid" } } }, "localname": "CommissionsPaidForIssuanceOrdinaryShares", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CommitmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments [Abstract]", "terseLabel": "Commitments and contingencies [Abstract]" } } }, "localname": "CommitmentsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "aciu_CommitmentsAndContingenciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and contingencies [Abstract]" } } }, "localname": "CommitmentsAndContingenciesAbstract", "nsuri": "http://acimume.com/20211231", "xbrltype": "stringItemType" }, "aciu_CommonSharesAuthorizedForIssuanceSalesInInOpenMarket": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of common shares authorized for sale in the open market.", "label": "Common shares authorized for issuance sales in in open market", "terseLabel": "Shares authorized for sale" } } }, "localname": "CommonSharesAuthorizedForIssuanceSalesInInOpenMarket", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ConditionalShareCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conditional share capital [Abstract]", "terseLabel": "Conditional Share Capital [Abstract]" } } }, "localname": "ConditionalShareCapitalAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "aciu_ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for share capital of the conditional share capital for bonds and similar debt instruments.", "label": "Conditional share capital for bonds and similar debt instruments [Member]", "terseLabel": "Bonds and Similar Debt Instruments [Member]" } } }, "localname": "ConditionalShareCapitalForBondsAndSimilarDebtInstrumentsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" ], "xbrltype": "domainItemType" }, "aciu_ConditionalShareCapitalForEmployeeBenefitPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for share capital of the conditional share capital for employee benefit plans.", "label": "Conditional share capital for employee benefit plans [Member]", "terseLabel": "Employee Benefit Plans [Member]" } } }, "localname": "ConditionalShareCapitalForEmployeeBenefitPlansMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "aciu_ContractAssetsAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase in contract assets for the period.", "label": "Contract assets, additions", "terseLabel": "Accrued income, additions" } } }, "localname": "ContractAssetsAdditions", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ContractAssetsDeductions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The decrease in contract assets for the period.", "label": "Contract assets, deductions", "negatedLabel": "Accrued income, deductions" } } }, "localname": "ContractAssetsDeductions", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ContractLiabilitiesAddition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase in contract liabilities for the period.", "label": "Contract liabilities, addition", "terseLabel": "Deferred income, additions" } } }, "localname": "ContractLiabilitiesAddition", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ContractLiabilitiesDeductions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The decrease in contract liabilities for the period.", "label": "Contract liabilities, deductions", "negatedLabel": "Deferred income, deductions" } } }, "localname": "ContractLiabilitiesDeductions", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ContractRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract Revenue [Abstract]", "terseLabel": "Contract Revenue [Abstract]" } } }, "localname": "ContractRevenueAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" ], "xbrltype": "stringItemType" }, "aciu_ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual undiscounted cash flows for lease liabilities [Abstract]", "terseLabel": "Contractual undiscounted cash flows for lease liabilities [Abstract]" } } }, "localname": "ContractualUndiscountedCashFlowsForLeaseLiabilitiesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "aciu_ConvertibleBorrowings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of debt identified as being convertible into another form of financial instrument.", "label": "Convertible borrowings", "terseLabel": "Aggregate principal amount" } } }, "localname": "ConvertibleBorrowings", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ConvertibleNoteAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Note Agreement [Abstract]" } } }, "localname": "ConvertibleNoteAgreementAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "stringItemType" }, "aciu_ConvertibleNoteAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represents to convertible note agreement.", "label": "Convertible Note Agreement [Member]", "terseLabel": "Convertible Note Agreement with Lilly [Member]", "verboseLabel": "Convertible Note Agreement [Member]" } } }, "localname": "ConvertibleNoteAgreementMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "domainItemType" }, "aciu_CurrentAccruedResearchAndDevelopmentCosts": { "auth_ref": [], "calculation": { "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails": { "order": 1.0, "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of current accrued research and development costs.", "label": "Current accrued research and development costs", "terseLabel": "Accrued research and development costs" } } }, "localname": "CurrentAccruedResearchAndDevelopmentCosts", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_CurrentReceivablesClassifiedAsOtherAndValueAddedAndWithholdingTaxes": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://acimume.com/role/OtherCurrentReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of current other receivables and receivables from value added taxes and withholding taxes.", "label": "Current receivables classified as other and value added and withholding taxes", "terseLabel": "Other current receivables", "totalLabel": "Total" } } }, "localname": "CurrentReceivablesClassifiedAsOtherAndValueAddedAndWithholdingTaxes", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_DecreaseInNetLossForeignExchangeRateIncrease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The decrease in net loss arising from a increase in the foreign exchange rate.", "label": "Decrease in net loss, foreign exchange rate increase", "terseLabel": "Net loss for period decrease, result of foreign exchange rate increase" } } }, "localname": "DecreaseInNetLossForeignExchangeRateIncrease", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "aciu_DecreaseInNetLossInterestRateDecrease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The decrease in net loss arising from a decrease in the interest rate.", "label": "Decrease in net loss, interest rate decrease", "terseLabel": "Net loss for period decrease, due to decrease in interest rate" } } }, "localname": "DecreaseInNetLossInterestRateDecrease", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "aciu_DefinedBenefitPlanPercentageOfContribution": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The contributions paid to the plan are computed as a percentage of salary, adjusted for the age of the employee.", "label": "Defined benefit plan, percentage of contribution", "terseLabel": "Contributions paid to the plan by computing percentage in salary" } } }, "localname": "DefinedBenefitPlanPercentageOfContribution", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "percentItemType" }, "aciu_DefinedBenefitsPlanEmployeeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the employee portion of a domestic defined benefit plan.", "label": "Defined benefits plan, Employee [Member]", "terseLabel": "Employee [Member]" } } }, "localname": "DefinedBenefitsPlanEmployeeMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "domainItemType" }, "aciu_DefinedBenefitsPlanEmployerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for the employee portion of a domestic defined benefit plan.", "label": "Defined benefits plan, Employer [Member]", "terseLabel": "Employer [Member]" } } }, "localname": "DefinedBenefitsPlanEmployerMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "domainItemType" }, "aciu_DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.", "label": "Description of accounting policy for accounting judgments and estimates [Policy Text Block]", "terseLabel": "Critical judgments and accounting estimates" } } }, "localname": "DescriptionOfAccountingPolicyForAccountingJudgmentsAndEstimatesPolicyTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aciu_DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.", "label": "Description of accounting policy for classification of assets and liabilities [Policy Text Block]", "terseLabel": "Current vs. non-current classification" } } }, "localname": "DescriptionOfAccountingPolicyForClassificationOfAssetsAndLiabilitiesPolicyTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aciu_DilutiveEffectOfConvertibleInstrumentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of instruments (including contingently issuable shares) that could potentially dilute basic earnings per share in the future.", "label": "Dilutive effect of convertible instruments [Text Block]", "terseLabel": "Antidilutive securities" } } }, "localname": "DilutiveEffectOfConvertibleInstrumentsTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "aciu_DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting": { "auth_ref": [], "calculation": { "http://acimume.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The number of dilutive restricted share awards subject to future vesting that relate to the assumed exercise of the entity's incentive share options.", "label": "Dilutive effect of Restricted share awards subject to future vesting", "terseLabel": "Restricted share awards subject to future vesting (in shares)" } } }, "localname": "DilutiveEffectOfRestrictedShareAwardsSubjectToFutureVesting", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares": { "auth_ref": [], "calculation": { "http://acimume.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options and potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments.", "label": "Dilutive effect of share options and convertible instruments on number of ordinary shares", "totalLabel": "Total (in shares)" } } }, "localname": "DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "aciu_DilutiveEffectOfShareOptionsIssuedAndOutstanding": { "auth_ref": [], "calculation": { "http://acimume.com/role/EarningsPerShareDetails": { "order": 0.0, "parentTag": "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The number of dilutive share options that relate to the assumed exercise of the entity's share options.", "label": "Dilutive effect of share options issued and outstanding", "terseLabel": "Share options issued and outstanding (in-the-money) (in shares)" } } }, "localname": "DilutiveEffectOfShareOptionsIssuedAndOutstanding", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "aciu_DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for changes to accounting policies recently adopted by the entity.", "label": "Disclosure Of Accounting Policy For Changes In Accounting Policies Recently Adopted [Text Block]", "terseLabel": "Accounting policies, new standards, interpretations and amendments adopted by the Company" } } }, "localname": "DisclosureOfAccountingPolicyForChangesInAccountingPoliciesRecentlyAdoptedTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.", "label": "Disclosure of detailed information about carrying amounts of financial assets and financial liabilities [Table Text Block]", "terseLabel": "Carrying amounts of financial assets and financial liabilities" } } }, "localname": "DisclosureOfDetailedInformationAboutCarryingAmountsOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementTables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about the expiration of income tax losses that may be carried forward.", "label": "Disclosure of detailed information about income tax losses expiry [Table Text Block]", "terseLabel": "Tax losses carry forwards and respective expiry dates" } } }, "localname": "DisclosureOfDetailedInformationAboutIncomeTaxLossesExpiryTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about income tax reconciliation.", "label": "Disclosure of detailed information about income tax reconciliation [Table Text Block]", "terseLabel": "Income tax expense reconciled to loss" } } }, "localname": "DisclosureOfDetailedInformationAboutIncomeTaxReconciliationTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other current receivables.", "label": "Disclosure of detailed information about other current receivables [Table Text Block]", "terseLabel": "Other current receivables" } } }, "localname": "DisclosureOfDetailedInformationAboutOtherCurrentReceivablesTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesTables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about prepaid expenses and accrued income.", "label": "Disclosure of detailed information about prepaid expenses and accrued income [Table Text Block]", "terseLabel": "Prepaid expenses and accrued income" } } }, "localname": "DisclosureOfDetailedInformationAboutPrepaidExpensesAndAccruedIncomeTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeTables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about trade payables and accrued liabilities.", "label": "Disclosure of detailed information about trade payables and accrued liabilities [Table Text Block]", "terseLabel": "Trade and other payables and accrued liabilities" } } }, "localname": "DisclosureOfDetailedInformationAboutTradePayablesAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for general information about the entity.", "label": "Disclosure of general information about the entity explanatory [Text Block]", "terseLabel": "General information" } } }, "localname": "DisclosureOfGeneralInformationAboutTheEntityExplanatoryTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/GeneralInformation" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Disclosure of information about commitments and contingencies [Line Items]" } } }, "localname": "DisclosureOfInformationAboutCommitmentsAndContingenciesLineItems", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "aciu_DisclosureOfInformationAboutCommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of disclosing information related to commitments and contingencies.", "label": "Disclosure of information about commitments and contingencies [Table]" } } }, "localname": "DisclosureOfInformationAboutCommitmentsAndContingenciesTable", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "stringItemType" }, "aciu_DisclosureOfOtherCurrentReceivablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Disclosure of other current receivables [Line Items]" } } }, "localname": "DisclosureOfOtherCurrentReceivablesLineItems", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "stringItemType" }, "aciu_DisclosureOfOtherCurrentReceivablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to other current receivables.", "label": "Disclosure of other current receivables [Table]" } } }, "localname": "DisclosureOfOtherCurrentReceivablesTable", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "stringItemType" }, "aciu_DisclosureOfOtherCurrentReceivablesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of other current receivables.", "label": "Disclosure of other current receivables [Text Block]", "terseLabel": "Other current receivables" } } }, "localname": "DisclosureOfOtherCurrentReceivablesTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/OtherCurrentReceivables" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfPrepaidExpensesAndAccruedIncomeTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of prepayments and accrued income.", "label": "Disclosure of prepaid expenses and accrued income [Text Block]", "terseLabel": "Prepaid expenses and accrued income" } } }, "localname": "DisclosureOfPrepaidExpensesAndAccruedIncomeTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncome" ], "xbrltype": "textBlockItemType" }, "aciu_DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.", "label": "Disclosure of right-of-use assets impact on statements [Text Block]", "verboseLabel": "Impact on Consolidated Statements of income/(loss) and Consolidated Statements of Cash Flows" } } }, "localname": "DisclosureOfRightOfUseAssetsImpactOnStatementsTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "aciu_DispositionsOfRightOfUseAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of decrease in right-of-use assets from disposals.", "label": "Dispositions of right-of-use assets", "negatedLabel": "Dispositions" } } }, "localname": "DispositionsOfRightOfUseAssets", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_EmployeeFullTimeEquivalentsInGeneralAndAdministrativeExpenses": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of employees calculated on full-time equivalents within general and administrative expenses.", "label": "Employee, full-time equivalents in general and administrative expenses", "terseLabel": "Full-time equivalents in general and administrative functions" } } }, "localname": "EmployeeFullTimeEquivalentsInGeneralAndAdministrativeExpenses", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "decimalItemType" }, "aciu_EmployeeFullTimeEquivalentsInResearchAndDevelopment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of employees calculated on full-time equivalents within research and development.", "label": "Employee, full-time equivalents in research and development", "terseLabel": "Full-time equivalents in research and development" } } }, "localname": "EmployeeFullTimeEquivalentsInResearchAndDevelopment", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "decimalItemType" }, "aciu_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to personnel employed by the entity.", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "aciu_EscrowDepositAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of deposits held in escrow.", "label": "Escrow deposit, amount", "terseLabel": "Escrow deposits" } } }, "localname": "EscrowDepositAmount", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_EstimatedLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Estimated lease term", "terseLabel": "Estimated lease term" } } }, "localname": "EstimatedLeaseTerm", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "aciu_ExecutiveManagementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Key managers, or ranking officers of an entity, appointed to their position by the board of directors.", "label": "Executive Management [Member]", "verboseLabel": "Executives [Member]" } } }, "localname": "ExecutiveManagementMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "domainItemType" }, "aciu_ExpenseRelatingToLeases": { "auth_ref": [], "calculation": { "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The expense for leases recognized through profit and loss.", "label": "Expense relating to leases", "totalLabel": "Total" } } }, "localname": "ExpenseRelatingToLeases", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ExpensesByCategoryAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses by category [Abstract]" } } }, "localname": "ExpensesByCategoryAbstract", "nsuri": "http://acimume.com/20211231", "xbrltype": "stringItemType" }, "aciu_ExpensesOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses, Operating [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "ExpensesOperatingAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "stringItemType" }, "aciu_FairValueOfFinancialAssetsAndLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for fair value of financial assets and liabilities.", "label": "Fair value of financial assets and liabilities [Policy Text Block]", "terseLabel": "Fair value of financial assets and liabilities" } } }, "localname": "FairValueOfFinancialAssetsAndLiabilitiesPolicyTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aciu_FinancialAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial assets and liabilities [Abstract]", "terseLabel": "Financial assets and liabilities [Abstract]" } } }, "localname": "FinancialAssetsAndLiabilitiesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "aciu_FinancialResultNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Result, net [Abstract]", "terseLabel": "Financial result, net [Abstract]" } } }, "localname": "FinancialResultNetAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "stringItemType" }, "aciu_FinancialRisksAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial risks [Abstract]", "terseLabel": "Financial risks [Abstract]" } } }, "localname": "FinancialRisksAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "aciu_FirstCapitalPartnerGmbHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder of Affiris.", "label": "First Capital Partner GmbH [Member]", "terseLabel": "First Capital Partner GmbH [Member]" } } }, "localname": "FirstCapitalPartnerGmbHMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "domainItemType" }, "aciu_GainLossArisingFromChangeInFairValueOfConvertibleInstrument": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 4.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gain (loss) arising from the change in fair value of a convertible instrument.", "label": "Gain (loss) arising from change in fair value of convertible instrument", "terseLabel": "Change in fair value of conversion feature" } } }, "localname": "GainLossArisingFromChangeInFairValueOfConvertibleInstrument", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_GeneralAndAdministrativeExpenseAllocationExpenseFromShareBasedPaymentTransactionsWithEmployees": { "auth_ref": [], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 2.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees allocated to general and administrative expense.", "label": "General and administrative expense allocation, expense from share-based payment transactions with employees", "terseLabel": "Share-based compensation" } } }, "localname": "GeneralAndAdministrativeExpenseAllocationExpenseFromShareBasedPaymentTransactionsWithEmployees", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_GeneralAndAdministrativeExpenseAllocationOperatingExpense": { "auth_ref": [], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 0.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of all operating expenses allocated to general and administrative expenses.", "label": "General and administrative expense allocation, operating expense", "terseLabel": "Operating expenses" } } }, "localname": "GeneralAndAdministrativeExpenseAllocationOperatingExpense", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_GeneralAndAdministrativeExpenseAllocationWagesAndSalaries": { "auth_ref": [], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 1.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries that are allocated to general and administrative expense. [Refer: Employee benefits expense]", "label": "General and administrative expense allocation, wages and salaries", "terseLabel": "Payroll expenses" } } }, "localname": "GeneralAndAdministrativeExpenseAllocationWagesAndSalaries", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_GeneralInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General information [Abstract]" } } }, "localname": "GeneralInformationAbstract", "nsuri": "http://acimume.com/20211231", "xbrltype": "stringItemType" }, "aciu_GoingConcernAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Going Concern [Abstract]", "terseLabel": "Going concern [Abstract]" } } }, "localname": "GoingConcernAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/BasisOfPreparationDetails" ], "xbrltype": "stringItemType" }, "aciu_GrantFromTargetALSFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Target ALS Foundation.", "label": "Grant from Target ALS Foundation [Member]", "terseLabel": "Grant from Target ALS Foundation [Member]" } } }, "localname": "GrantFromTargetALSFoundationMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails" ], "xbrltype": "domainItemType" }, "aciu_GrantIncomePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for grant income.", "label": "Grant income [Policy Text Block]", "terseLabel": "Grant income" } } }, "localname": "GrantIncomePolicyTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "aciu_GrantRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue earned from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.", "label": "Grant revenue [Member]", "terseLabel": "Grant revenue [Member]" } } }, "localname": "GrantRevenueMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails" ], "xbrltype": "domainItemType" }, "aciu_GrantsMichaelJFoxFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Funding provided for certain types of expenditures in connection with research and development activities over a contractually-defined period from the Michael J. Fox Foundation.", "label": "Grants, Michael J. Fox Foundation [Member]", "terseLabel": "Grant from Michael J. Fox Foundation [Member]", "verboseLabel": "MJFF Grants [Member]" } } }, "localname": "GrantsMichaelJFoxFoundationMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "domainItemType" }, "aciu_ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact on statements of income/(loss) and cash flows [Abstract]", "terseLabel": "Impact on statements of income/(loss) and cash flows [Abstract]" } } }, "localname": "ImpactOnStatementsOfIncomeLossAndCashFlowsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "aciu_InProcessResearchAndDevelopmentIPRDAssetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for an intangible asset that is a clinically-validated active vaccine candidate for the treatment of Parkinson's disease.", "label": "In-process Research and Development (IPR&D) Asset [Member]", "terseLabel": "IPR&D [Member]" } } }, "localname": "InProcessResearchAndDevelopmentIPRDAssetMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "domainItemType" }, "aciu_IncomeTaxLossCarryforwardPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Income tax loss, Carryforward period", "terseLabel": "Tax loss carryforward period" } } }, "localname": "IncomeTaxLossCarryforwardPeriod", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "durationItemType" }, "aciu_IncreaseDecreaseInPlanAssetsOfDefinedBenefitPlanAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan.", "label": "Increase (decrease) in plan assets of defined benefit plan, amount", "terseLabel": "Increase in plan assets" } } }, "localname": "IncreaseDecreaseInPlanAssetsOfDefinedBenefitPlanAmount", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "aciu_IncreaseDecreaseInPlanAssetsOfDefinedBenefitPlanPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of increase (decrease) in plan assets of defined benefit plan.", "label": "Increase (decrease) in plan assets of defined benefit plan, percentage", "terseLabel": "Percentage increase in plan assets" } } }, "localname": "IncreaseDecreaseInPlanAssetsOfDefinedBenefitPlanPercentage", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "percentItemType" }, "aciu_IncreaseDecreaseThroughAcquisitionOfAssetsEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "'The increase (decrease) in equity resulting from the issuance of shares as part of an asset acquisition.", "label": "Increase (decrease) through acquisition of assets, equity", "terseLabel": "Asset acquisition - common shares" } } }, "localname": "IncreaseDecreaseThroughAcquisitionOfAssetsEquity", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "aciu_IncreaseDecreaseThroughPurchaseOfAssetsEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from purchase of assets.", "label": "Increase (decrease) through purchase of assets, equity", "verboseLabel": "Asset purchase agreement, net of transaction costs" } } }, "localname": "IncreaseDecreaseThroughPurchaseOfAssetsEquity", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "aciu_IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from purchase of IPR&D assets.", "label": "Increase (decrease) through purchase of in process research and development asset", "terseLabel": "IPR&D asset purchase" } } }, "localname": "IncreaseDecreaseThroughPurchaseOfInProcessResearchAndDevelopmentAsset", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "aciu_IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity shares resulting from treasury share transactions.", "label": "Increase (decrease) through treasury share transactions, equity, shares", "terseLabel": "Issuance of shares to be held as treasury shares, net of transaction costs (in shares)" } } }, "localname": "IncreaseDecreaseThroughTreasuryShareTransactionsEquityShares", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_IncreaseInNetLossInterestRateIncrease": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase in net loss arising from a increase in the interest rate.", "label": "Increase in net loss, interest rate increase", "terseLabel": "Net loss for period increase, due to increase in interest rate" } } }, "localname": "IncreaseInNetLossInterestRateIncrease", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase in the number of ordinary shares issued under a convertible debt arrangement upon conversion of the debt.", "label": "Increase in number of ordinary shares issued under conversion of convertible debt", "terseLabel": "Conversion of note agreement, net of transaction costs (in shares)", "verboseLabel": "Number of shares in conversion of debt (in shares)" } } }, "localname": "IncreaseInNumberOfOrdinarySharesIssuedUnderConversionOfConvertibleDebt", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "sharesItemType" }, "aciu_IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase in the number of ordinary shares issued under incentive plans.", "label": "Increase in number of ordinary shares issued under incentive plans", "terseLabel": "Issuance of shares - incentive plans, net of transaction costs (in shares)" } } }, "localname": "IncreaseInNumberOfOrdinarySharesIssuedUnderIncentivePlans", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_IncreaseInNumberOfSharesIssuedShareBasedPaymentArrangementOtherEquityInstrumentsNetOfExpirationAndForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase in number of equity instruments issued resulting from the issue of shares under share-based payment arrangements equity instruments other that share options net of expirations and forfeitures.", "label": "Increase in number of shares issued, share-based payment arrangement, other equity instruments net of expiration and forfeiture", "terseLabel": "Issuance of shares - incentive plans, net of RSU expiration and forfeiture (in shares)" } } }, "localname": "IncreaseInNumberOfSharesIssuedShareBasedPaymentArrangementOtherEquityInstrumentsNetOfExpirationAndForfeiture", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_IncreaseInNumberOfSharesIssuedThroughPurchaseOfAssetsEquity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The increase in the number of ordinary shares issued under asset purchase.", "label": "Increase in number of shares issued through purchase of assets, equity", "verboseLabel": "Asset purchase agreement, net of transaction costs (in shares)" } } }, "localname": "IncreaseInNumberOfSharesIssuedThroughPurchaseOfAssetsEquity", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_IncreaseThroughSharesIssuedShareBasedPaymentArrangementOtherEquityInstrumentsNetOfExpirationAndForfeiture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase in equity resulting from the issue of shares under share-based payment arrangements equity instruments other that share options net of expirations and forfeitures.", "label": "Increase through shares issued, share-based payment arrangement, other equity instruments net of expiration and forfeiture", "terseLabel": "Issuance of shares - incentive plans, net of RSU expiration and forfeiture" } } }, "localname": "IncreaseThroughSharesIssuedShareBasedPaymentArrangementOtherEquityInstrumentsNetOfExpirationAndForfeiture", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "aciu_IncreaseThroughSharesIssuedUnderIncentivePlans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase in equity resulting from the issue of shares under incentive plans.", "label": "Increase through shares issued under incentive plans", "verboseLabel": "Issuance of shares - incentive plans, net of transaction costs" } } }, "localname": "IncreaseThroughSharesIssuedUnderIncentivePlans", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "aciu_InterestCostNetDefinedBenefitLiabilityAsset": { "auth_ref": [], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": 0.0, "parentTag": "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAsset", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The decrease in the net defined benefit liability (asset) resulting from interest costs resulting from the passage of time.", "label": "Interest cost, net defined benefit liability (asset)", "negatedLabel": "Interest cost", "terseLabel": "Interest cost" } } }, "localname": "InterestCostNetDefinedBenefitLiabilityAsset", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "aciu_InterestIncomeNetDefinedBenefitLiabilityAsset": { "auth_ref": [], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAsset", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase in the net defined benefit liability (asset) resulting from the passage of time.", "label": "Interest income, net defined benefit liability (asset)", "negatedLabel": "Interest income", "terseLabel": "Interest income" } } }, "localname": "InterestIncomeNetDefinedBenefitLiabilityAsset", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "aciu_IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The Issuance of shares for purchase of IPR&D asset in asset acquisition.", "label": "Issuance of shares for purchase of IPR&D asset in asset acquisition" } } }, "localname": "IssuanceOfSharesForPurchaseOfIPRDAssetInAssetAcquisition", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_IssueOfEquityRestrictedShareAwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase in equity through the issue of restricted share awards.", "label": "Issue of Equity, Restricted Share Awards", "terseLabel": "Restricted share awards" } } }, "localname": "IssueOfEquityRestrictedShareAwards", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "aciu_IssuedActuarialTablesSwitzerland": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Published actuarial tables that detail assumptions about mortality and disability rates which are used to determine benefit obligations for defined benefit plans.", "label": "Issued Actuarial Tables, Switzerland", "terseLabel": "Mortality and disability rates" } } }, "localname": "IssuedActuarialTablesSwitzerland", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "aciu_LaboratoryEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing laboratory equipment.", "label": "Laboratory equipment [Member]", "terseLabel": "Laboratory Equipment [Member]" } } }, "localname": "LaboratoryEquipmentMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "aciu_LeaseholdImprovementsAndFixturesAndFittingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement and fixtures and fittings that are not permanently attached to real property.", "label": "Leasehold improvements and fixtures and fittings [Member]", "terseLabel": "Leasehold Improvements/Furniture [Member]" } } }, "localname": "LeaseholdImprovementsAndFixturesAndFittingsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "aciu_LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2014 contractual research agreement associated with collaboration with Life Molecular Imaging.", "label": "License and collaboration agreement of 2014, Life Molecular Imaging [Member]", "terseLabel": "2014 Agreement with Life Molecular Imaging (formerly Piramal Imaging SA) [Member]", "verboseLabel": "Life Molecular Imaging [Member]" } } }, "localname": "LicenseAndCollaborationAgreementOf2014LifeMolecularImagingMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "domainItemType" }, "aciu_LiquidityManagementRollingForecastPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The periodic interval in which the entity performs a rolling forecast of the entity's cash position, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Liquidity management, rolling forecast period", "terseLabel": "Cash position rolling forecast period" } } }, "localname": "LiquidityManagementRollingForecastPeriod", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "durationItemType" }, "aciu_LongTermFinancialAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents financial assets classified as long-term.", "label": "Long-term Financial Assets [Member]" } } }, "localname": "LongTermFinancialAssetsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Maximum term of options granted for share-based payment arrangement", "terseLabel": "Contractual life of options" } } }, "localname": "MaximumTermOfOptionsGrantedForShareBasedPaymentArrangement", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "durationItemType" }, "aciu_MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum term of other equity instruments (ie other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Maximum Term Of Other Equity Instruments Granted For Share Based Payment Arrangement", "terseLabel": "Contractual life of options" } } }, "localname": "MaximumTermOfOtherEquityInstrumentsGrantedForShareBasedPaymentArrangement", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "durationItemType" }, "aciu_MilestonePaymentsClinicalAndRegulatoryMilestonesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to a milestone payment arrangement related to clinical and regulatory milestones.", "label": "Milestone payments, clinical and regulatory milestones [Member]", "terseLabel": "Clinical and Regulatory [Member]" } } }, "localname": "MilestonePaymentsClinicalAndRegulatoryMilestonesMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_MilestonePaymentsCommercialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to a milestone payment arrangement related to certain commercial milestones.", "label": "Milestone payments, commercial [Member]", "terseLabel": "Commercial [Member]" } } }, "localname": "MilestonePaymentsCommercialMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_NetPensionCostInStatementOfIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net pension cost in statement of income [Abstract]", "terseLabel": "Net pension cost in statement of income [Abstract]" } } }, "localname": "NetPensionCostInStatementOfIncomeAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "stringItemType" }, "aciu_NumberOfConvertibleNotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of convertible notes with Affiris affiliated entities.", "label": "Number of convertible notes", "terseLabel": "Number of convertible notes", "verboseLabel": "Number of separate convertible note agreements" } } }, "localname": "NumberOfConvertibleNotes", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfDepositsInEscrowAccounts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of deposits in escrow accounts.", "label": "Number of deposits in escrow accounts" } } }, "localname": "NumberOfDepositsInEscrowAccounts", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfEquityBasedInstrumentPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of equity-based instrument plans approved by the entity.", "label": "Number of Equity-based Instrument Plans", "terseLabel": "Number of equity-based instrument plans" } } }, "localname": "NumberOfEquityBasedInstrumentPlans", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.", "label": "Number of financial institutions holding, cash and cash equivalents and short-term financial assets", "terseLabel": "Number of financial institutions holding cash and cash equivalents and short-term financial assets" } } }, "localname": "NumberOfFinancialInstitutionsHoldingCashAndCashEquivalentsAndShortTermFinancialAssets", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfGrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of grants received.", "label": "Number of grants", "terseLabel": "Number of grants received" } } }, "localname": "NumberOfGrants", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfMilestonePaymentsReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of times payment(s) received for milestone payments associated with a collaborative agreement.", "label": "Number of milestone payments received", "terseLabel": "Number of milestone payments received" } } }, "localname": "NumberOfMilestonePaymentsReceived", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfNonVestedSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number Of Non-vested Shares [Abstract]", "terseLabel": "Number of non-vested shares [Abstract]" } } }, "localname": "NumberOfNonVestedSharesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "stringItemType" }, "aciu_NumberOfOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Options [Abstract]", "terseLabel": "Number of options [Abstract]" } } }, "localname": "NumberOfOptionsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "stringItemType" }, "aciu_NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised in a share-based payment arrangement.", "label": "Number of other equity instruments exercised in share-based payment arrangement", "negatedLabel": "Exercised during the year (in shares)" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisedInShareBasedPaymentArrangement", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "aciu_NumberOfOtherEquityInstrumentsExpiredOrForfeitedInShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of other equity instruments (ie other than share options) expired or forfeited in a share-based payment arrangement.", "label": "Number of other equity instruments expired or forfeited in share-based payment arrangement", "terseLabel": "Number of RSUs either expired or forfeited (in shares)" } } }, "localname": "NumberOfOtherEquityInstrumentsExpiredOrForfeitedInShareBasedPaymentArrangement", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_NumberOfPerformanceObligationsIdentified": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of performance obligations identified applicable to the entity's assessment of a specific contractual arrangement.", "label": "Number of performance obligations identified", "terseLabel": "Number of performance obligations identified" } } }, "localname": "NumberOfPerformanceObligationsIdentified", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfPersonsKeyManagementBoardOfDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.", "label": "Number of persons, key management, Board of Directors", "terseLabel": "Number of individuals, Board of Directors" } } }, "localname": "NumberOfPersonsKeyManagementBoardOfDirectors", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfPersonsKeyManagementExecutiveManagement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of persons that comprise key management of the entity that are Executive Management.", "label": "Number of persons, key management, Executive Management", "terseLabel": "Number of individuals, Executive Management" } } }, "localname": "NumberOfPersonsKeyManagementExecutiveManagement", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfRepresentativesInJointSteeringCommitteeByEachParty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of representatives in a joint steering committee by each party as per the agreement.", "label": "Number of representatives in joint steering committee by each party", "terseLabel": "Number of representatives in joint steering committee by each party" } } }, "localname": "NumberOfRepresentativesInJointSteeringCommitteeByEachParty", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "integerItemType" }, "aciu_NumberOfSharesOutstandingIncludingTreasuryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares that have been authorized and issued, including treasury shares held. [Refer: Treasury shares]", "label": "Number of shares outstanding including treasury shares", "periodEndLabel": "Balance, end of period (in shares)", "periodStartLabel": "Balance, beginning of period (in shares)" } } }, "localname": "NumberOfSharesOutstandingIncludingTreasuryShares", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_NumberOfTechnologyPlatforms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.", "label": "Number of technology platforms", "terseLabel": "Number of proprietary technology platforms" } } }, "localname": "NumberOfTechnologyPlatforms", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/GeneralInformationDetails" ], "xbrltype": "integerItemType" }, "aciu_OperatingSegmentsNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operating segments reported by the entity.", "label": "Operating segments, number", "terseLabel": "Number of operating segments" } } }, "localname": "OperatingSegmentsNumber", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "aciu_OtherAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "contractual research agreement associated with collaboration with other.", "label": "Other agreement [Member]", "verboseLabel": "Other [Member]" } } }, "localname": "OtherAgreementMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" ], "xbrltype": "domainItemType" }, "aciu_OtherComprehensiveGainsLossesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive gains (losses) [Abstract]", "terseLabel": "Other comprehensive gains/(losses) [Abstract]" } } }, "localname": "OtherComprehensiveGainsLossesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "aciu_OtherCurrentReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other current receivables [Abstract]" } } }, "localname": "OtherCurrentReceivablesAbstract", "nsuri": "http://acimume.com/20211231", "xbrltype": "stringItemType" }, "aciu_OtherReceivablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents receivables classified as other.", "label": "Other receivables [Member]", "terseLabel": "Other Current Receivables [Member]" } } }, "localname": "OtherReceivablesMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Options Exercise Price Range and Expiry Dates [Abstract]", "terseLabel": "Outstanding options, exercise price range and expiry dates [Abstract]" } } }, "localname": "OutstandingOptionsExercisePriceRangeAndExpiryDatesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "stringItemType" }, "aciu_PercentageIncreaseInPropertyPlantAndEquipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of increase in property, plant and equipment during the period.", "label": "Percentage increase in property, plant and equipment", "terseLabel": "Percentage of increase in equipment" } } }, "localname": "PercentageIncreaseInPropertyPlantAndEquipment", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "percentItemType" }, "aciu_PercentageOfAccruedIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage that represents the percentage of total accrued income.", "label": "Percentage of Accrued Income", "terseLabel": "Percentage of accrued income" } } }, "localname": "PercentageOfAccruedIncome", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "percentItemType" }, "aciu_PercentageOfDecreaseInInterestRates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage decrease to interest rate at the end of the reporting period.", "label": "Percentage of decrease in interest rates", "terseLabel": "Percentage of decrease in interest rates" } } }, "localname": "PercentageOfDecreaseInInterestRates", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "percentItemType" }, "aciu_PercentageOfIncreaseInInterestRates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage increase to interest rate at the end of the reporting period.", "label": "Percentage of increase in interest rates", "terseLabel": "Percentage of increase in interest rates" } } }, "localname": "PercentageOfIncreaseInInterestRates", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "percentItemType" }, "aciu_PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation.", "label": "Percentage of reasonably possible decrease in actuarial assumption [Member]", "terseLabel": "-0.5% Decrease [Member]" } } }, "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumptionMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "aciu_PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation.", "label": "Percentage of reasonably possible increase in actuarial assumption [Member]", "terseLabel": "+0.5% Increase [Member]" } } }, "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumptionMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "aciu_PeriodOfMaturityReceivablesFairValueCarryingAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Refers to the maturity period over which the entity considers carrying value of current receivables to correspond to their fair value, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period of maturity, receivables fair value carrying amount", "terseLabel": "Maturity period of assets" } } }, "localname": "PeriodOfMaturityReceivablesFairValueCarryingAmount", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "durationItemType" }, "aciu_PhaseTwoClinicalStudyLicensedProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance obligation related to a phase 2 clinical study of a licensed product.", "label": "Phase two clinical study, licensed product [Member]", "terseLabel": "Phase 2 Clinical Study Licensed Product [Member]" } } }, "localname": "PhaseTwoClinicalStudyLicensedProductMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_PotentialIncreaseIsEquityThroughIssueOfEquityInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The potential increase in equity from the possible issuance of equity instruments.", "label": "Potential increase is equity through issue of equity instruments", "terseLabel": "Maximum aggregate amount of registered shares" } } }, "localname": "PotentialIncreaseIsEquityThroughIssueOfEquityInstruments", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "aciu_PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The potential increase in equity from share-based payment transactions.", "label": "Potential increase is equity through share-based payment transactions", "terseLabel": "Maximum aggregate amount of ordinary shares" } } }, "localname": "PotentialIncreaseIsEquityThroughShareBasedPaymentTransactions", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "aciu_PotentialNumberOfSharesIssuedFromIssueOfEquityInstruments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The total number of potential shares issued from issue of equity instruments.", "label": "Potential number of shares issued from issue of equity instruments", "terseLabel": "Issuance of registered shares (in shares)" } } }, "localname": "PotentialNumberOfSharesIssuedFromIssueOfEquityInstruments", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "aciu_PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The total number of potential shares issued through share-based payment transactions.", "label": "Potential number of shares issued from share-based payment transactions", "verboseLabel": "Issuance of ordinary shares (in shares)" } } }, "localname": "PotentialNumberOfSharesIssuedFromShareBasedPaymentTransactions", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" ], "xbrltype": "sharesItemType" }, "aciu_PrepaidExpensesAndAccruedIncomeDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid expenses and accrued income, Disclosure [Abstract]", "terseLabel": "Prepaid expenses and accrued income [Abstract]" } } }, "localname": "PrepaidExpensesAndAccruedIncomeDisclosureAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "stringItemType" }, "aciu_PrepaidExpensesAndAccruedIncomeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Prepaid Expenses and Accrued Income [Line Items]" } } }, "localname": "PrepaidExpensesAndAccruedIncomeLineItems", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "stringItemType" }, "aciu_PrepaidExpensesAndAccruedIncomeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to details of Prepaid expenses and accrued income.", "label": "Prepaid Expenses and Accrued Income [Table]" } } }, "localname": "PrepaidExpensesAndAccruedIncomeTable", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "stringItemType" }, "aciu_ProceedsFromIssueOfConvertibleDebt": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuing of convertible debt.", "label": "Proceeds from issue of convertible debt", "terseLabel": "Proceeds from issuance of convertible loan", "verboseLabel": "Net proceeds" } } }, "localname": "ProceedsFromIssueOfConvertibleDebt", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ProceedsFromPurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities": { "auth_ref": [], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sales of financial instruments and the cash outflow for the purchase of financial instruments. [Refer: Financial instruments, class [member]]", "label": "Proceeds from (purchase) of financial instruments, classified as investing activities", "terseLabel": "Short-term financial assets" } } }, "localname": "ProceedsFromPurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property plant and equipment estimated useful life [Abstract]", "terseLabel": "Estimated useful life [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLifeAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "aciu_ProvisionsResearchContracts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of provisions for research and development contracts with external providers.", "label": "Provisions, research contracts", "terseLabel": "External research projects" } } }, "localname": "ProvisionsResearchContracts", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of property plant and equipment acquired through noncash investing activities.", "label": "Purchase of property, plant and equipment, classified as noncash investing activities", "terseLabel": "Capital expenditures recorded in Accrued expenses" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsNoncashInvestingActivities", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_RangeOfExercisePricesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for exercise of price range one.", "label": "Range of Exercise Prices one [Member]", "terseLabel": "CHF 0.15 [Member]" } } }, "localname": "RangeOfExercisePricesOneMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "domainItemType" }, "aciu_RangeOfExercisePricesThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for exercise of price range three", "label": "Range Of Exercise Prices Three [Member]", "terseLabel": "USD 5.04 to USD 12.30 [Member]" } } }, "localname": "RangeOfExercisePricesThreeMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "domainItemType" }, "aciu_RangeOfExercisePricesTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for exercise of price range two.", "label": "Range Of Exercise Prices Two [Member]", "terseLabel": "CHF 9.53 [Member]" } } }, "localname": "RangeOfExercisePricesTwoMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "domainItemType" }, "aciu_RentalContractPeriodForNoticeOfCancellation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time required by the lessee in a lease agreement to provide notice of cancellation of a lease to the lessor, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Rental contract, period for notice of cancellation", "terseLabel": "Notice period for cancellation of rental contract" } } }, "localname": "RentalContractPeriodForNoticeOfCancellation", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "durationItemType" }, "aciu_RepaymentOfConvertibleDebtEquitySettlementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of the settlement of convertible debt that is settled via shares of entity's common shares.", "label": "Repayment of convertible debt, Equity Settlement, Amount", "terseLabel": "Settlement of convertible notes recorded within Shareholders' equity" } } }, "localname": "RepaymentOfConvertibleDebtEquitySettlementAmount", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "aciu_ReportableSegmentsNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reportable segments reported by the entity.", "label": "Reportable segments, number", "terseLabel": "Number of reportable segments" } } }, "localname": "ReportableSegmentsNumber", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "aciu_ResearchAndDevelopmentExpenseAllocationExpenseFromShareBasedPaymentTransactionsWithEmployees": { "auth_ref": [], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 2.0, "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees that are allocated to research and development expenses.", "label": "Research and development expense allocation, expense from share-based payment transactions with employees", "terseLabel": "Share-based compensation" } } }, "localname": "ResearchAndDevelopmentExpenseAllocationExpenseFromShareBasedPaymentTransactionsWithEmployees", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ResearchAndDevelopmentExpenseAllocationOperatingExpense": { "auth_ref": [], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 0.0, "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of all operating expenses allocated to research and development expenses.", "label": "Research and development expense allocation, operating expense", "terseLabel": "Operating expenses" } } }, "localname": "ResearchAndDevelopmentExpenseAllocationOperatingExpense", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ResearchAndDevelopmentExpenseAllocationWagesAndSalaries": { "auth_ref": [], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 1.0, "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries that are allocated to research and development expenses. [Refer: Employee benefits expense]", "label": "Research and development expense allocation, wages and salaries", "terseLabel": "Payroll expenses" } } }, "localname": "ResearchAndDevelopmentExpenseAllocationWagesAndSalaries", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "aciu_ResearchAndDevelopmentExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development Expenses [Abstract]", "terseLabel": "Research and Development [Abstract]" } } }, "localname": "ResearchAndDevelopmentExpensesAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "stringItemType" }, "aciu_ResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance obligation related to research and development.", "label": "Research and development [Member]", "terseLabel": "Research and Development [Member]" } } }, "localname": "ResearchAndDevelopmentMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_RestrictedSharesAndRestrictedShareUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Shares and Restricted Share Units [Member]", "terseLabel": "Non-vested Share Awards [Member]" } } }, "localname": "RestrictedSharesAndRestrictedShareUnitsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "domainItemType" }, "aciu_RestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for equity instruments that are convertible to stock after a specified period of time.", "label": "Restricted Stock Units [Member]", "terseLabel": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "domainItemType" }, "aciu_RevenueReclassifiedToOtherIncomeExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of revenue reclassified to other income (expense).", "label": "Revenue reclassified to other income (expense)", "terseLabel": "Amount reclassified from contract revenue to other income/(expense)" } } }, "localname": "RevenueReclassifiedToOtherIncomeExpense", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "aciu_RightOfUseFinancialAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for right-of-use financial assets.", "label": "Right of use financial assets [Member]", "terseLabel": "Right-of-use Assets [Member]" } } }, "localname": "RightOfUseFinancialAssetsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_RightOfUseLeasedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right-of-use leased assets [Abstract]", "terseLabel": "Right-of-use of leased assets [Abstract]" } } }, "localname": "RightOfUseLeasedAssetsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "aciu_RightOfUseLicenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance obligation related to right-of-use license.", "label": "Right-of-use license [Member]", "terseLabel": "Right-of-use License [Member]" } } }, "localname": "RightOfUseLicenseMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_SaleOrIssueOfTreasurySharesShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of treasury shares issued or sold.", "label": "Sale or issue of treasury shares, shares", "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs (in shares)", "verboseLabel": "Number of treasury share issued (in shares)" } } }, "localname": "SaleOrIssueOfTreasurySharesShares", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "aciu_ScheduleOfContractualUndiscountedCashFlowsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to the contractual undiscounted cash flows.", "label": "Schedule of contractual undiscounted cash flows [Table Text Block]", "terseLabel": "Contractual Undiscounted Cash Flows" } } }, "localname": "ScheduleOfContractualUndiscountedCashFlowsTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "aciu_ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about the estimated lease term by right-of-use asset by category.", "label": "Schedule of information about contract lease term by right-of-use asset categories [Table Text Block]", "terseLabel": "Estimated Lease Term by Right-of-use Asset Categories" } } }, "localname": "ScheduleOfInformationAboutContractLeaseTermByRightOfUseAssetCategoriesTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "aciu_ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about the useful life of property, plant and equipment.", "label": "Schedule of information about property, plant and equipment useful life [Table Text Block]", "terseLabel": "Estimated useful life" } } }, "localname": "ScheduleOfInformationAboutPropertyPlantAndEquipmentUsefulLifeTableTextBlock", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "aciu_SecondOpenMarketSalesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for entity entered into a second Open Market Sales Agreement (the \"New Sales Agreement\") with Jefferies to continue the ATM program.", "label": "Second Open Market Sales Agreement [Member]", "terseLabel": "New Sales Agreement [Member]" } } }, "localname": "SecondOpenMarketSalesAgreementMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "domainItemType" }, "aciu_SensitivityAnalysisActuarialAssumptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sensitivity analysis, actuarial assumptions [Abstract]", "terseLabel": "Sensitivity analysis [Abstract]" } } }, "localname": "SensitivityAnalysisActuarialAssumptionsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "aciu_ShareBasedPaymentArrangementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based payment arrangement [Abstract]" } } }, "localname": "ShareBasedPaymentArrangementAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "stringItemType" }, "aciu_ShareBasedPlansOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based plans outstanding [Abstract]", "terseLabel": "Share-based plans outstanding [Abstract]" } } }, "localname": "ShareBasedPlansOutstandingAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "stringItemType" }, "aciu_ShareOptionsDateOfExpiry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The date on which share options will expired.", "label": "Share Options Date of Expiry", "terseLabel": "Expiration Dates" } } }, "localname": "ShareOptionsDateOfExpiry", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "gYearItemType" }, "aciu_ShelfRegistrationStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shelf Registration Statement [Abstract]" } } }, "localname": "ShelfRegistrationStatementAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalShelfRegistrationStatementDetails" ], "xbrltype": "stringItemType" }, "aciu_ShelfRegistrationStatementSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of common stock, debt securities, warrants, purchase contracts, units, subscription rights or any combination of the foregoing in one or more future public offerings authorized for sale by the entity through a Shelf Registration Statement.", "label": "Shelf Registration Statement, shares authorized", "terseLabel": "Shares authorized under Shelf Registration Statement (in shares)" } } }, "localname": "ShelfRegistrationStatementSharesAuthorized", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ShareCapitalShelfRegistrationStatementDetails" ], "xbrltype": "sharesItemType" }, "aciu_ShortTermFinancialAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents financial assets classified as short-term.", "label": "Short-term Financial Assets [Member]" } } }, "localname": "ShortTermFinancialAssetsMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_ShortTermLeaseLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for short-term lease liabilities.", "label": "Short-term lease liabilities [Member]", "terseLabel": "Short-term Lease Liabilities [Member]" } } }, "localname": "ShortTermLeaseLiabilitiesMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_SkaneUniversityHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Skane University Hospital is a university hospital in Scania, Sweden.", "label": "Skane University Hospital [Member]", "terseLabel": "Skane University Hospital [Member]" } } }, "localname": "SkaneUniversityHospitalMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails" ], "xbrltype": "domainItemType" }, "aciu_StockOptionPlanC1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A share-based payment arrangement that existed at any time during the reporting period.", "label": "Stock option plan C1 [Member]", "terseLabel": "Share Option Plan C1 [Member]" } } }, "localname": "StockOptionPlanC1Member", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "aciu_SupplementalNonCashActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental non-cash activity [Abstract]", "terseLabel": "Supplemental non-cash activity" } } }, "localname": "SupplementalNonCashActivityAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "aciu_TauMorphomerSmallMoleculeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The research and development of medicines for the treatment of Alzheimer's disease and other neurodegenerative diseases.", "label": "Tau Morphomer Small Molecule [Member]", "terseLabel": "Morphomer Tau Small Molecule [Member]" } } }, "localname": "TauMorphomerSmallMoleculeMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "aciu_TauPETImagingAgentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The research and development of medicines for the treatment of Alzheimer's disease through molecular imaging.", "label": "Tau-PET imaging agent [Member]", "terseLabel": "Tau-PET Imaging Agent [Member]" } } }, "localname": "TauPETImagingAgentMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "domainItemType" }, "aciu_TauVaccineInADMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The research and development of a vaccine for the treatment of Alzheimer's disease.", "label": "Tau Vaccine in AD [Member]", "terseLabel": "Tau Vaccine in AD [Member]" } } }, "localname": "TauVaccineInADMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" ], "xbrltype": "domainItemType" }, "aciu_TaxLossesSplitByExpiryDateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tax losses split by expiry date [Abstract]", "terseLabel": "Tax losses split by expiry date [Abstract]" } } }, "localname": "TaxLossesSplitByExpiryDateAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "aciu_TradeAndOtherPayablesAndAccruedLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.", "label": "Trade and other payables and accrued liabilities [Line Items]" } } }, "localname": "TradeAndOtherPayablesAndAccruedLiabilitiesLineItems", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "stringItemType" }, "aciu_TradeAndOtherPayablesAndAccruedLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to details of trade and other payables and accrued liabilities.", "label": "Trade and other payables and accrued liabilities [Table]" } } }, "localname": "TradeAndOtherPayablesAndAccruedLiabilitiesTable", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "stringItemType" }, "aciu_TradeAndOtherPayablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for trade and other payables.", "label": "Trade and Other Payables [Member]" } } }, "localname": "TradeAndOtherPayablesMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "aciu_Two016ShareOptionAndIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.", "label": "2016 Share Option and Incentive Plan [Member]", "terseLabel": "2016 SOIP [Member]" } } }, "localname": "Two016ShareOptionAndIncentivePlanMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting tranche one of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.", "label": "2016 Share Option and Incentive Plan, Vesting Tranche One [Member]", "terseLabel": "2016 SOIP, Vesting Condition 1 [Member]" } } }, "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheOneMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting tranche three of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.", "label": "2016 Share Option and Incentive Plan, Vesting Tranche Three [Member]", "terseLabel": "2016 SOIP, Vesting Condition 3 [Member]" } } }, "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheThreeMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "aciu_Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting tranche two of the 2016 Plan authorizes the grant of incentive and non-qualified share options, share appreciation rights, restricted share awards, restricted share units, unrestricted share awards, performance share awards, performance-based awards to covered employees and dividend equivalent rights.", "label": "2016 Share Option and Incentive Plan, Vesting Tranche Two [Member]", "terseLabel": "2016 SOIP, Vesting Condition 2 [Member]" } } }, "localname": "Two016ShareOptionAndIncentivePlanVestingTrancheTwoMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "aciu_UndiscountedOperatingLeasePaymentsDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of undiscounted operating lease payments due for lease liabilities.", "label": "Undiscounted operating lease payments due", "terseLabel": "Contractual undiscounted cash flows for lease liabilities" } } }, "localname": "UndiscountedOperatingLeasePaymentsDue", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "aciu_UnusedTaxCreditsRetirementBenefitPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for tax credits that have been received and are carried forward for use against future taxable profit related to the retirement benefit plan.", "label": "Unused tax credits, Retirement benefit plan [Member]", "terseLabel": "Deductible Temporary Differences Related to Retirement Benefit Plan [Member]" } } }, "localname": "UnusedTaxCreditsRetirementBenefitPlanMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "aciu_UnusedTaxCreditsRightOfUseAssetsAndLeaseLiabilitiesNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for tax credits that have been received and are carried forward for use against future taxable profit related to right-of-use assets and lease liabilities.", "label": "Unused tax credits, Right-of-use assets and lease liabilities net [Member]", "terseLabel": "Deductible Temporary Differences Related to Right-of-use Assets and Lease Liabilities [Member]" } } }, "localname": "UnusedTaxCreditsRightOfUseAssetsAndLeaseLiabilitiesNetMember", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "aciu_VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For vesting requirements for a type of share-based payment arrangement that existed at any time during the period, this element represents the period which an employees' right to exercise an award is no longer contingent on satisfaction of a service condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Vesting requirements for share-based payment arrangement, award vesting period", "terseLabel": "Vesting conditions", "verboseLabel": "Vesting conditions" } } }, "localname": "VestingRequirementsForShareBasedPaymentArrangementAwardVestingPeriod", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "durationItemType" }, "aciu_WeightedAverageAssumptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Assumptions [Abstract]", "terseLabel": "Weighted average assumptions [Abstract]" } } }, "localname": "WeightedAverageAssumptionsAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "stringItemType" }, "aciu_WeightedAverageExercisePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted average exercise price [Abstract]", "verboseLabel": "Weighted Average grant date fair value [Abstract]" } } }, "localname": "WeightedAverageExercisePriceAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "stringItemType" }, "aciu_WeightedAverageExercisePriceOfNonVestedOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average exercise price of non-vested other equity instruments (ie other than share options) granted in a share-based payment arrangement.", "label": "Weighted average exercise price of non-vested other equity instruments granted in share-based payment arrangement", "terseLabel": "Weighted average fair value, non-vested restricted share awards granted (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfNonVestedOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "aciu_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised in a share-based payment arrangement. [Refer: Weighted average [member]]", "label": "Weighted average exercise price of other equity instruments exercised in sharebased payment arrangement2019", "terseLabel": "Exercised during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedInSharebasedPaymentArrangement2019", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "aciu_WeightedAverageRemainingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Remaining [Abstract]", "verboseLabel": "Weighted average remaining term (years) [Abstract]" } } }, "localname": "WeightedAverageRemainingAbstract", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "stringItemType" }, "aciu_WeightedAverageRemainingContractualLifeOfExercisableShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of exercisable share options.", "label": "Weighted average remaining contractual life of exercisable share options", "terseLabel": "Exercisable" } } }, "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions", "nsuri": "http://acimume.com/20211231", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "currency_CHF": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Switzerland, Francs", "terseLabel": "CHF [Member]" } } }, "localname": "CHF", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "EUR [Member]" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "currency_USD": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "United States of America, Dollars", "terseLabel": "USD [Member]" } } }, "localname": "USD", "nsuri": "http://xbrl.sec.gov/currency/2021", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "domainItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r269", "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r269", "r270", "r271" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r269", "r270", "r271" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r269", "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Addresses [Line Items]" } } }, "localname": "EntityAddressesLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressesTable": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Container of address information for the entity", "label": "Entity Addresses [Table]" } } }, "localname": "EntityAddressesTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r273" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r269", "r270", "r271" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://acimume.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "ifrs-full_AccrualsClassifiedAsCurrent": { "auth_ref": [ "r31" ], "calculation": { "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails": { "order": 4.0, "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accruals classified as current. [Refer: Accruals]" } }, "en-us": { "role": { "label": "Accruals classified as current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccrualsClassifiedAsCurrent", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "auth_ref": [ "r58", "r65", "r113", "r120", "r123" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]" } }, "en-us": { "role": { "label": "Accumulated depreciation and amortisation [member]", "terseLabel": "Accumulated Depreciation [Member]" } } }, "localname": "AccumulatedDepreciationAndAmortisationMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "auth_ref": [ "r210" ], "calculation": { "http://acimume.com/role/AssetAcquisitionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Consideration transferred, acquisition-date fair value", "totalLabel": "Total" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transferred assets acquired [abstract]" } } }, "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of discount rates", "terseLabel": "Discount rate" } } }, "localname": "ActuarialAssumptionOfDiscountRates", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of discount rates [member]", "terseLabel": "Discount Rate [Member]" } } }, "localname": "ActuarialAssumptionOfDiscountRatesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of pension increases", "terseLabel": "Rate of future increase in current pensions" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "This member stands for the expected rates of pension increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of pension increases [member]", "terseLabel": "Future Pension Cost [Member]" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of salary increases", "terseLabel": "Rate of future increase in compensations" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "This member stands for the expected rates of salary increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Actuarial assumption of expected rates of salary increases [member]", "terseLabel": "Future Salary Increase [Member]" } } }, "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialAssumptionsAxis": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Actuarial assumptions [axis]" } } }, "localname": "ActuarialAssumptionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ActuarialAssumptionsMember": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used." } }, "en-us": { "role": { "label": "Actuarial assumptions [member]" } } }, "localname": "ActuarialAssumptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r74" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails": { "order": 0.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Effect of changes in demographic assumptions", "terseLabel": "Change in demographic assumptions" } } }, "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r75" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Effect of changes in financial assumptions", "terseLabel": "Change in financial assumptions" } } }, "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r76" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails": { "order": 2.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Change in experience assumptions", "terseLabel": "Effect of changes in experience assumptions" } } }, "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "auth_ref": [ "r59" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "terseLabel": "Acquisitions" } } }, "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdditionsToRightofuseAssets": { "auth_ref": [ "r184" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Additions and remeasurements" } } }, "localname": "AdditionsToRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustedWeightedAverageShares": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share", "terseLabel": "Weighted-average number of shares outstanding - diluted to equity holders (in shares)" } } }, "localname": "AdjustedWeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "auth_ref": [ "r132" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in other operating receivables", "terseLabel": "(Increase)/decrease in other current receivables" } } }, "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationExpense": { "auth_ref": [ "r134" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for depreciation expense", "terseLabel": "Depreciation of property, plant and equipment" } } }, "localname": "AdjustmentsForDepreciationExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForFairValueGainsLosses": { "auth_ref": [ "r133" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for fair value losses (gains)", "terseLabel": "Change in fair value of conversion feature" } } }, "localname": "AdjustmentsForFairValueGainsLosses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForFinanceIncomeCost": { "auth_ref": [ "r134" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for finance income (cost)", "negatedLabel": "Finance result, net" } } }, "localname": "AdjustmentsForFinanceIncomeCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": { "auth_ref": [ "r134" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]" } }, "en-us": { "role": { "label": "Adjustments for gain (loss) on disposals, property, plant and equipment", "negatedLabel": "(Gain)/loss on sale of fixed assets" } } }, "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInContractLiabilities": { "auth_ref": [ "r132" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for the increase (decrease) in contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Contract liabilities; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in contract liabilities", "terseLabel": "Increase /(decrease) in deferred income" } } }, "localname": "AdjustmentsForIncreaseDecreaseInContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": { "auth_ref": [ "r134" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in employee benefit liabilities", "terseLabel": "Changes in net employee defined benefit liability" } } }, "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r132" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade accounts payable", "terseLabel": "(Decrease)/increase in trade and other payables" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForInterestExpense": { "auth_ref": [ "r134" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for interest expense", "terseLabel": "Interest expense" } } }, "localname": "AdjustmentsForInterestExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile profit (loss) [abstract]", "terseLabel": "Adjustments to reconcile net income/(loss) for the period to net cash flows:" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r133" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AggregatedTimeBandsMember": { "auth_ref": [ "r24", "r85", "r174", "r187", "r188", "r218", "r230", "r234", "r250", "r251", "r253", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } }, "en-us": { "role": { "label": "Aggregated time bands [member]" } } }, "localname": "AggregatedTimeBandsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails", "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r114" ], "lang": { "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Accumulated Amortization" } } }, "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ApplicableTaxRate": { "auth_ref": [ "r48" ], "lang": { "en": { "role": { "documentation": "The applicable income tax rate." } }, "en-us": { "role": { "label": "Applicable tax rate", "terseLabel": "Corporate tax rate" } } }, "localname": "ApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r21", "r158", "r159", "r160", "r241", "r244" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_AverageEffectiveTaxRate": { "auth_ref": [ "r48" ], "lang": { "en": { "role": { "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Average effective tax rate" } } }, "localname": "AverageEffectiveTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_AverageForeignExchangeRate": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies." } }, "en-us": { "role": { "label": "Average exchange rate, USD 1" } } }, "localname": "AverageForeignExchangeRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_BasicEarningsLossPerShare": { "auth_ref": [ "r103", "r104" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } }, "en-us": { "role": { "label": "Basic earnings (loss) per share", "terseLabel": "Basic income/(loss) for the period attributable to equity holders (in CHF per share)" } } }, "localname": "BasicEarningsLossPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_BasicEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic earnings per share [abstract]", "terseLabel": "Basic income/(loss) per share (EPS) [Abstract]" } } }, "localname": "BasicEarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameAxis": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Borrowings by name [axis]" } } }, "localname": "BorrowingsByNameAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_BorrowingsByNameMember": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings by name [member]" } } }, "localname": "BorrowingsByNameMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r162", "r163", "r164", "r202", "r228", "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom of range [member]", "terseLabel": "Bottom of Range [Member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BuildingsMember": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Buildings [member]", "terseLabel": "Buildings [Member]" } } }, "localname": "BuildingsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r211" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "auth_ref": [ "r58", "r62", "r113", "r115", "r119", "r120", "r121", "r122", "r123", "r212", "r223", "r224", "r262", "r264" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortization and impairment and gross carrying amount [axis]", "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } } }, "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails", "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CarryingAmountMember": { "auth_ref": [ "r62", "r115", "r119", "r121", "r122", "r212", "r223", "r224", "r262", "r263" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Carrying amount [member]" } } }, "localname": "CarryingAmountMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails", "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash [abstract]", "terseLabel": "Cash and cash equivalents [Abstract]" } } }, "localname": "CashAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r17", "r139", "r155" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents, end of period", "periodStartLabel": "Cash and cash equivalents, beginning of period", "terseLabel": "Company's cash position" } } }, "localname": "CashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/BasisOfPreparationDetails", "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails", "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r124", "r140" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Net cash flows provided by/(used in) financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities [abstract]", "terseLabel": "Financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r124", "r140" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash flows (used in)/provided by investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities [abstract]", "terseLabel": "Investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r124", "r140" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Net cash flows (used in)/provided by operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities [abstract]", "terseLabel": "Operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperations": { "auth_ref": [ "r134", "r141" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash from (used in) the entity's operations." } }, "en-us": { "role": { "label": "Cash flows from (used in) operations", "totalLabel": "Cash (used in)/provided by operating activities" } } }, "localname": "CashFlowsFromUsedInOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashOutflowForLeases": { "auth_ref": [ "r183" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for leases." } }, "en-us": { "role": { "label": "Cash outflow for leases", "terseLabel": "Total cash outflow for leases" } } }, "localname": "CashOutflowForLeases", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashTransferred": { "auth_ref": [ "r207" ], "calculation": { "http://acimume.com/role/AssetAcquisitionDetails": { "order": 0.0, "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Cash" } } }, "localname": "CashTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CategoriesOfFinancialAssetsAxis": { "auth_ref": [ "r229" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of financial assets [axis]" } } }, "localname": "CategoriesOfFinancialAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": { "auth_ref": [ "r229" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of financial liabilities [axis]" } } }, "localname": "CategoriesOfFinancialLiabilitiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r98" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share capital [Abstract]" } } }, "localname": "ChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in net defined benefit liability (asset) [abstract]", "terseLabel": "Changes in defined benefit obligation [Abstract]", "verboseLabel": "Change in net defined benefit liability [Abstract]" } } }, "localname": "ChangesInNetDefinedBenefitLiabilityAssetAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfAssetsAxis": { "auth_ref": [ "r107", "r109", "r161", "r186" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of assets [axis]" } } }, "localname": "ClassesOfAssetsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfAssetsMember": { "auth_ref": [ "r107", "r161", "r186" ], "lang": { "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } }, "en-us": { "role": { "label": "Assets [member]" } } }, "localname": "ClassesOfAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "auth_ref": [ "r116" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } } }, "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "auth_ref": [ "r63" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } } }, "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalAxis": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of share capital [axis]" } } }, "localname": "ClassesOfShareCapitalAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalMember": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } }, "en-us": { "role": { "label": "Share Capital [member]", "terseLabel": "Share capital [member]" } } }, "localname": "ClassesOfShareCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ClosingForeignExchangeRate": { "auth_ref": [ "r10" ], "lang": { "en": { "role": { "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery." } }, "en-us": { "role": { "label": "Closing rate, USD 1", "terseLabel": "Translation rate into CHF" } } }, "localname": "ClosingForeignExchangeRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items that may be reclassified to income or loss in subsequent periods (net of tax):" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]", "terseLabel": "Items that will not be reclassified to income or loss in subsequent periods (net of tax):" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r3", "r38", "r144", "r146", "r147", "r152" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Total comprehensive income/(loss), net of tax" } } }, "localname": "ComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComputerEquipmentMember": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Computer equipment [member]", "terseLabel": "IT Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ContractAssets": { "auth_ref": [ "r165", "r168" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer, when that right is conditioned on something other than the passage of time (for example, the entity\u2019s future performance)." } }, "en-us": { "role": { "label": "Contract assets", "terseLabel": "Deferred research and development costs" } } }, "localname": "ContractAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContractLiabilities": { "auth_ref": [ "r165", "r168" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer." } }, "en-us": { "role": { "label": "Contract liabilities", "terseLabel": "Up-front consideration received" } } }, "localname": "ContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r78" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer", "negatedLabel": "Employer's contribution", "verboseLabel": "Employer's contributions" } } }, "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r78" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants", "terseLabel": "Employees' contributions" } } }, "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CounterpartiesAxis": { "auth_ref": [ "r235" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Counterparties [axis]" } } }, "localname": "CounterpartiesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_CounterpartiesMember": { "auth_ref": [ "r235" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } }, "en-us": { "role": { "label": "Counterparties [member]" } } }, "localname": "CounterpartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CreditRiskMember": { "auth_ref": [ "r220", "r254", "r255", "r256" ], "lang": { "en": { "role": { "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Credit risk [member]", "terseLabel": "Credit Risk [Member]" } } }, "localname": "CreditRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CurrencyRiskMember": { "auth_ref": [ "r237", "r254", "r255", "r256", "r257" ], "lang": { "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Currency risk [member]", "terseLabel": "Foreign Currency Exchange Risk [Member]" } } }, "localname": "CurrencyRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 }, "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]" } }, "en-us": { "role": { "label": "Current accrued expenses and other current liabilities", "terseLabel": "Accrued expenses", "totalLabel": "Total accrued expenses" } } }, "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r25", "r147", "r148" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets [abstract]", "terseLabel": "Current assets" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentContractAssets": { "auth_ref": [ "r165" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails": { "order": 1.0, "parentTag": "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current contract assets. [Refer: Contract assets]" } }, "en-us": { "role": { "label": "Current contract assets", "periodEndLabel": "Accrued income, ending balance", "periodStartLabel": "Accrued income, beginning balance", "terseLabel": "Accrued income" } } }, "localname": "CurrentContractAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentContractLiabilities": { "auth_ref": [ "r165" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]" } }, "en-us": { "role": { "label": "Current contract liabilities", "periodEndLabel": "Deferred income, ending balance", "periodStartLabel": "Deferred income, beginning balance", "terseLabel": "Deferred income", "verboseLabel": "Deferred income" } } }, "localname": "CurrentContractLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/ContractRevenuesChangesInContractAssetsAndLiabilitiesDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentFinancialAssets": { "auth_ref": [ "r219" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current financial assets. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Short-term financial assets", "verboseLabel": "Short-term financial assets due in one year or less" } } }, "localname": "CurrentFinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/BasisOfPreparationDetails", "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsAndShorttermFinancialAssetsDetails", "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r179" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Short-term lease liabilities" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r26", "r147", "r150" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "terseLabel": "Current liabilities" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentPrepayments": { "auth_ref": [ "r28" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails": { "order": 0.0, "parentTag": "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current prepayments. [Refer: Prepayments]" } }, "en-us": { "role": { "label": "Current prepayments", "terseLabel": "Prepaid expenses" } } }, "localname": "CurrentPrepayments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets": { "auth_ref": [ "r21", "r31" ], "calculation": { "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current prepayments and current accrued income including current contract assets. [Refer: Prepayments; Accrued income including contract assets]" } }, "en-us": { "role": { "label": "Current prepayments and current accrued income including current contract assets", "totalLabel": "Total" } } }, "localname": "CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid expenses and accrued income [Abstract]" } } }, "localname": "CurrentPrepaymentsAndCurrentAccruedIncomeIncludingCurrentContractAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "auth_ref": [ "r29" ], "calculation": { "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails": { "order": 2.0, "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } }, "en-us": { "role": { "label": "Current provisions for employee benefits", "terseLabel": "Accrued payroll expenses" } } }, "localname": "CurrentProvisionsForEmployeeBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": { "auth_ref": [ "r28" ], "calculation": { "http://acimume.com/role/OtherCurrentReceivablesDetails": { "order": 2.0, "parentTag": "aciu_CurrentReceivablesClassifiedAsOtherAndValueAddedAndWithholdingTaxes", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } }, "en-us": { "role": { "label": "Current receivables from taxes other than income tax", "terseLabel": "Withholding tax" } } }, "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r72" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": 2.0, "parentTag": "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAsset", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Increase in net defined benefit liability (asset) resulting from current service cost", "negatedLabel": "Service cost", "terseLabel": "Service cost" } } }, "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentValueAddedTaxReceivables": { "auth_ref": [ "r28" ], "calculation": { "http://acimume.com/role/OtherCurrentReceivablesDetails": { "order": 1.0, "parentTag": "aciu_CurrentReceivablesClassifiedAsOtherAndValueAddedAndWithholdingTaxes", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]" } }, "en-us": { "role": { "label": "Current value added tax receivables", "terseLabel": "Swiss VAT" } } }, "localname": "CurrentValueAddedTaxReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxAssets": { "auth_ref": [ "r20", "r22", "r50" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Deferred tax assets", "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits" } } }, "localname": "DeferredTaxAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets and liabilities [abstract]" } } }, "localname": "DeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DeferredTaxLiabilities": { "auth_ref": [ "r20", "r22", "r50" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } }, "en-us": { "role": { "label": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DeferredTaxLiabilityAsset": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } }, "en-us": { "role": { "label": "Deferred tax liability (asset)", "terseLabel": "Unused tax losses and tax credits" } } }, "localname": "DeferredTaxLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefinedBenefitObligationAtPresentValue": { "auth_ref": [ "r88" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": 0.0, "parentTag": "ifrs-full_SurplusDeficitInPlan", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]" } }, "en-us": { "role": { "label": "Defined benefit obligation, at present value", "negatedTerseLabel": "Defined benefit obligation" } } }, "localname": "DefinedBenefitObligationAtPresentValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefinedBenefitPlansAxis": { "auth_ref": [ "r68" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Defined benefit plans [axis]" } } }, "localname": "DefinedBenefitPlansAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DefinedBenefitPlansMember": { "auth_ref": [ "r68" ], "lang": { "en": { "role": { "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used." } }, "en-us": { "role": { "label": "Defined benefit plans [member]" } } }, "localname": "DefinedBenefitPlansMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember": { "auth_ref": [ "r86" ], "lang": { "en": { "role": { "documentation": "This member stands for defined benefit plans that share risks between entities under common control such as a parent and its subsidiaries. [Refer: Defined benefit plans [member]; Subsidiaries [member]; Parent [member]]" } }, "en-us": { "role": { "label": "Defined benefit plans that share risks between entities under common control [member]", "terseLabel": "Defined Benefit Plan [Member]" } } }, "localname": "DefinedBenefitPlansThatShareRisksBetweenEntitiesUnderCommonControlMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "auth_ref": [ "r61", "r64" ], "lang": { "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } }, "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "negatedLabel": "Depreciation expense" } } }, "localname": "DepreciationPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationRightofuseAssets": { "auth_ref": [ "r180" ], "calculation": { "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails": { "order": 0.0, "parentTag": "aciu_ExpenseRelatingToLeases", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } }, "en-us": { "role": { "label": "Depreciation, right-of-use assets", "negatedLabel": "Depreciation", "terseLabel": "Depreciation of right-of-use assets" } } }, "localname": "DepreciationRightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for earnings per share." } }, "en-us": { "role": { "label": "Description of accounting policy for earnings per share [text block]", "terseLabel": "Earnings per share" } } }, "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment." } }, "en-us": { "role": { "label": "Description of accounting policy for employee benefits [text block]", "terseLabel": "Employee benefits" } } }, "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for expenses." } }, "en-us": { "role": { "label": "General and administrative expenses" } } }, "localname": "DescriptionOfAccountingPolicyForExpensesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for foreign currency translation." } }, "en-us": { "role": { "label": "Description of accounting policy for foreign currency translation [text block]", "terseLabel": "Foreign currency transactions" } } }, "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates." } }, "en-us": { "role": { "label": "Description of accounting policy for functional currency [text block]", "terseLabel": "Functional and reporting currency" } } }, "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for income tax." } }, "en-us": { "role": { "label": "Description of accounting policy for income tax [text block]", "terseLabel": "Taxation" } } }, "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } }, "en-us": { "role": { "label": "Description of accounting policy for intangible assets and goodwill [text block]", "terseLabel": "Intangible Assets" } } }, "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for issued capital. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Description of accounting policy for issued capital [text block]", "terseLabel": "Share capital and public offerings" } } }, "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } }, "en-us": { "role": { "label": "Leases" } } }, "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Description of accounting policy for property, plant and equipment [text block]", "terseLabel": "Property, plant and equipment" } } }, "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]" } }, "en-us": { "role": { "label": "Description of accounting policy for provisions [text block]", "terseLabel": "Provisions" } } }, "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Description of accounting policy for recognition of revenue [text block]", "terseLabel": "Revenue recognition" } } }, "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]" } }, "en-us": { "role": { "label": "Description of accounting policy for research and development expense [text block]", "terseLabel": "Research and development expenses" } } }, "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for segment reporting." } }, "en-us": { "role": { "label": "Description of accounting policy for segment reporting [text block]", "terseLabel": "Segment reporting" } } }, "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": { "auth_ref": [ "r11" ], "lang": { "en": { "role": { "documentation": "The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Description of accounting policy for treasury shares [text block]", "terseLabel": "Treasury Shares" } } }, "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": { "auth_ref": [ "r110", "r111" ], "lang": { "en": { "role": { "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]" } }, "en-us": { "role": { "label": "Discount rate applied to cash flow projections", "terseLabel": "Discount rate" } } }, "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Expected volatility, share options granted", "terseLabel": "Expected volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The option life of share options granted." } }, "en-us": { "role": { "label": "Option life, share options granted", "terseLabel": "Expected term" } } }, "localname": "DescriptionOfOptionLifeShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk free interest rate, share options granted", "terseLabel": "Risk free interest rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r103", "r104" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Diluted income/(loss) for the period attributable to equity holders (in CHF per share)" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_DilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Diluted income/(loss) per share (EPS) [Abstract]" } } }, "localname": "DilutedEarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares": { "auth_ref": [ "r105" ], "calculation": { "http://acimume.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "aciu_DilutiveEffectOfShareOptionsAndConvertibleInstrumentsOnNumberOfOrdinaryShares", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The number of dilutive potential ordinary shares that relate to the assumed conversion of the entity's convertible instruments." } }, "en-us": { "role": { "label": "Dilutive effect of convertible instruments on number of ordinary shares", "terseLabel": "Convertible shares (in shares)" } } }, "localname": "DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options." } }, "en-us": { "role": { "label": "Dilutive effect of share options on number of ordinary shares", "terseLabel": "Effect of dilutive securities from equity incentive plans (in shares)" } } }, "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory": { "auth_ref": [ "r96" ], "lang": { "en": { "role": { "documentation": "The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]" } }, "en-us": { "role": { "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]", "terseLabel": "Key management compensation" } } }, "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } }, "en-us": { "role": { "label": "Basis of consolidation" } } }, "localname": "DisclosureOfBasisOfConsolidationExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } }, "en-us": { "role": { "label": "Disclosure of basis of preparation of financial statements [text block]", "terseLabel": "Basis of preparation" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/BasisOfPreparation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset acquisition [Abstract]" } } }, "localname": "DisclosureOfBusinessCombinationsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "auth_ref": [ "r214" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for business combinations." } }, "en-us": { "role": { "label": "Disclosure of business combinations [text block]", "verboseLabel": "Asset acquisition" } } }, "localname": "DisclosureOfBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisition" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [line items]" } } }, "localname": "DisclosureOfBusinessCombinationsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r211" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital structure [Abstract]" } } }, "localname": "DisclosureOfClassesOfShareCapitalAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [text block]", "terseLabel": "Summary of capital structure" } } }, "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } } }, "localname": "DisclosureOfClassesOfShareCapitalLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "auth_ref": [ "r34" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } } }, "localname": "DisclosureOfClassesOfShareCapitalTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } }, "en-us": { "role": { "label": "Disclosure of commitments and contingent liabilities [text block]", "terseLabel": "Commitments and contingencies" } } }, "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": { "auth_ref": [ "r112" ], "lang": { "en": { "role": { "documentation": "The disclosure of contingent liabilities. [Refer: Contingent liabilities [member]]" } }, "en-us": { "role": { "label": "Disclosure of contingent liabilities [text block]", "terseLabel": "Maturity of commitments and contingencies" } } }, "localname": "DisclosureOfContingentLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDefinedBenefitPlansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement benefit plan [Abstract]" } } }, "localname": "DisclosureOfDefinedBenefitPlansAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } }, "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } } }, "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": { "auth_ref": [ "r215" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about business combinations. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [text block]", "terseLabel": "Summary of transferred assets acquired" } } }, "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "auth_ref": [ "r116" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Net book value of intangible assets" } } }, "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r63" ], "lang": { "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [text block]", "terseLabel": "Property, plant and equipment" } } }, "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [abstract]", "terseLabel": "Contract revenues [Abstract]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "auth_ref": [ "r167" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } }, "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for earnings per share." } }, "en-us": { "role": { "label": "Disclosure of earnings per share [text block]", "terseLabel": "Earnings per share" } } }, "localname": "DisclosureOfEarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": { "auth_ref": [ "r91" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for the effect of changes in foreign exchange rates." } }, "en-us": { "role": { "label": "Exchange Rates Used for Translation of Financial statements" } } }, "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for employee benefits." } }, "en-us": { "role": { "label": "Disclosure of employee benefits [text block]", "terseLabel": "Retirement benefit plan" } } }, "localname": "DisclosureOfEmployeeBenefitsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlan" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "auth_ref": [ "r45" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } }, "en-us": { "role": { "label": "Subsequent events" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfExpensesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of expenses." } }, "en-us": { "role": { "label": "Disclosure of expenses [text block]", "terseLabel": "Expenses by category" } } }, "localname": "DisclosureOfExpensesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategory" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueOfPlanAssetsExplanatory": { "auth_ref": [ "r81" ], "lang": { "en": { "role": { "documentation": "The disclosure of the fair value of defined benefit plan assets. [Refer: Plan assets [member]; Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Disclosure of fair value of plan assets [text block]", "terseLabel": "Changes in defined benefit obligation, fair value of plan assets and unrecognized gains/(losses)" } } }, "localname": "DisclosureOfFairValueOfPlanAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } }, "en-us": { "role": { "label": "Financial Result, net" } } }, "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents and financial assets [Abstract]" } } }, "localname": "DisclosureOfFinancialAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "auth_ref": [ "r228" ], "lang": { "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Cash and cash equivalents and short-term financial assets" } } }, "localname": "DisclosureOfFinancialAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } }, "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "terseLabel": "Financial instruments and risk management" } } }, "localname": "DisclosureOfFinancialRiskManagementExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]" } }, "en-us": { "role": { "label": "Disclosure of general and administrative expense [text block]", "terseLabel": "General and Administrative" } } }, "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for income taxes." } }, "en-us": { "role": { "label": "Income taxes" } } }, "localname": "DisclosureOfIncomeTaxExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": { "auth_ref": [ "r205" ], "lang": { "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options." } }, "en-us": { "role": { "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]", "terseLabel": "Weighted-average assumptions" } } }, "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of significant accounting policies [Abstract]" } } }, "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangible assets [Abstract]" } } }, "localname": "DisclosureOfIntangibleAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "auth_ref": [ "r118" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for intangible assets." } }, "en-us": { "role": { "label": "Intangible assets" } } }, "localname": "DisclosureOfIntangibleAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]" } } }, "localname": "DisclosureOfIntangibleAssetsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsMaterialToEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of intangible assets material to entity [abstract]" } } }, "localname": "DisclosureOfIntangibleAssetsMaterialToEntityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "auth_ref": [ "r116" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } }, "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } } }, "localname": "DisclosureOfIntangibleAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfLeasesExplanatory": { "auth_ref": [ "r190", "r191" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for leases." } }, "en-us": { "role": { "label": "Right-of-use assets and lease liabilities" } } }, "localname": "DisclosureOfLeasesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilities" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of maturity analysis of operating lease payments [line items]" } } }, "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable": { "auth_ref": [ "r188" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the maturity analysis of operating lease payments." } }, "en-us": { "role": { "label": "Disclosure of maturity analysis of operating lease payments [table]" } } }, "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial instruments and risk management [Abstract]" } } }, "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [line items]" } } }, "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable": { "auth_ref": [ "r221", "r222" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the nature and extent of risks arising from financial instruments." } }, "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [table]" } } }, "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": { "auth_ref": [ "r71" ], "lang": { "en": { "role": { "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [text block]", "terseLabel": "Defined benefit pension plan amounts recognized in balance sheets and statement of income/(loss)" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [line items]" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": { "auth_ref": [ "r71" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)." } }, "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [table]" } } }, "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent events [Abstract]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]", "terseLabel": "Summary of non-vested share awards (restricted share and restricted share units)" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "auth_ref": [ "r200" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Disclosure of number and weighted average exercise prices of share options [text block]", "terseLabel": "Number and weighted average exercise prices of options under share option programs" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]", "terseLabel": "Number and weighted average exercise prices of options under the share option programs [Abstract]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "auth_ref": [ "r202" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]", "terseLabel": "Outstanding options, exercise price range and expiry dates" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "auth_ref": [ "r202" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } }, "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital risk management [Abstract]" } } }, "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": { "auth_ref": [ "r13" ], "lang": { "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital." } }, "en-us": { "role": { "label": "Disclosure of objectives, policies and processes for managing capital [text block]", "terseLabel": "Capital risk management" } } }, "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CapitalRiskManagement" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [abstract]", "terseLabel": "Segment reporting [Abstract]" } } }, "localname": "DisclosureOfOperatingSegmentsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [Abstract]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "auth_ref": [ "r66" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of property, plant and equipment [text block]", "terseLabel": "Property, plant and equipment" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r63" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } }, "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } } }, "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about leases for lessee [abstract]", "terseLabel": "Right-of-use assets and lease liabilities [Abstract]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "auth_ref": [ "r186" ], "lang": { "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [text block]", "terseLabel": "Information about Right-of-Use Assets" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [line items]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": { "auth_ref": [ "r186" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to right-of-use assets." } }, "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [table]" } } }, "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of range of exercise prices of outstanding share options [line items]" } } }, "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable": { "auth_ref": [ "r202" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the range of exercise prices of outstanding share options." } }, "en-us": { "role": { "label": "Disclosure of range of exercise prices of outstanding share options [table]" } } }, "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r99" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Disclosure of related party [text block]", "terseLabel": "Related-party transactions" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RelatedpartyTransactions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } }, "en-us": { "role": { "label": "Disclosure of research and development expense [text block]", "terseLabel": "Research and Development" } } }, "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents and financial assets" } } }, "localname": "DisclosureOfRestrictedCashAndCashEquivalentsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssets" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue." } }, "en-us": { "role": { "label": "Disclosure of revenue [text block]", "terseLabel": "Contract revenues" } } }, "localname": "DisclosureOfRevenueExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenues" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": { "auth_ref": [ "r177", "r178" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue from contracts with customers." } }, "en-us": { "role": { "label": "Disclosure of revenue from contracts with customers [text block]", "terseLabel": "Contract Revenues" } } }, "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [abstract]", "terseLabel": "Actuarial assumptions [Abstract]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]" } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]", "terseLabel": "Actuarial assumptions and sensitivity analysis" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions." } }, "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]" } } }, "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "auth_ref": [ "r35" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } }, "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]", "terseLabel": "Share capital" } } }, "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "auth_ref": [ "r192" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of share-based payment arrangements [text block]", "terseLabel": "Share-based compensation" } } }, "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "auth_ref": [ "r12" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for significant accounting policies applied by the entity." } }, "en-us": { "role": { "label": "Disclosure of significant accounting policies [text block]", "terseLabel": "Summary of significant accounting policies" } } }, "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]", "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits [Abstract]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]" } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]", "terseLabel": "Unrecognized deductible temporary differences, unused tax losses and unused tax credits" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } }, "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } } }, "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based compensation [Abstract]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The disclosure of the general terms and conditions of share-based payment arrangements. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [text block]", "terseLabel": "Share-based compensation plans outstanding" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other payables [text block]", "terseLabel": "Trade and other payables and accrued expenses" } } }, "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpenses" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related-party transactions [Abstract]" } } }, "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Disposals, property, plant and equipment", "negatedLabel": "Disposals" } } }, "localname": "DisposalsPropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings per share [Abstract]", "terseLabel": "Earnings/(loss) per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_EarningsPerShareExplanatory": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "The disclosure of earnings per share." } }, "en-us": { "role": { "label": "Earnings per share [text block]", "terseLabel": "Earnings per share" } } }, "localname": "EarningsPerShareExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r135", "r136" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "terseLabel": "Exchange losses on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r211", "r213" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for business combinations [member]" } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails", "http://acimume.com/role/ShareCapitalConvertibleNoteAgreementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r98" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for related parties [member]" } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r21", "r30", "r143", "r145", "r158", "r159", "r160" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period", "totalLabel": "Total shareholders' equity" } } }, "localname": "Equity", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' equity" } } }, "localname": "EquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total shareholders' equity and liabilities" } } }, "localname": "EquityAndLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS' EQUITY AND LIABILITIES" } } }, "localname": "EquityAndLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } }, "en-us": { "role": { "label": "Equity [Member]" } } }, "localname": "EquityMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The exercise price of share options granted." } }, "en-us": { "role": { "label": "Exercise price (in USD per share)" } } }, "localname": "ExercisePriceShareOptionsGranted2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Dividend yield" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "auth_ref": [ "r10" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } }, "en-us": { "role": { "label": "Expense from share-based payment transactions with employees", "verboseLabel": "Expense charged against the income statement" } } }, "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": { "auth_ref": [ "r182" ], "calculation": { "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "aciu_ExpenseRelatingToLeases", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease." } }, "en-us": { "role": { "label": "Expense relating to short-term leases for which recognition exemption has been used", "terseLabel": "Expense for short-term leases and leases of low value" } } }, "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory": { "auth_ref": [ "r171" ], "lang": { "en": { "role": { "documentation": "The explanation of the significant changes in the contract assets and the contract liabilities. [Refer: Contract assets; Contract liabilities]" } }, "en-us": { "role": { "label": "Changes in Contract Assets and Contract Liabilities" } } }, "localname": "ExplanationOfSignificantChangesInContractAssetsAndContractLiabilitiesExplanatory", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_FinanceCosts": { "auth_ref": [ "r40" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 4.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 2.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } }, "en-us": { "role": { "label": "Finance costs", "negatedLabel": "Financial expense" } } }, "localname": "FinanceCosts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities": { "auth_ref": [ "r137" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for finance costs paid, classified as operating activities. [Refer: Finance costs]" } }, "en-us": { "role": { "label": "Finance costs paid, classified as operating activities", "negatedLabel": "Finance costs" } } }, "localname": "FinanceCostsPaidClassifiedAsOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncome": { "auth_ref": [ "r42" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 3.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 1.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } }, "en-us": { "role": { "label": "Financial income", "terseLabel": "Financial income" } } }, "localname": "FinanceIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncomeCost": { "auth_ref": [ "r42" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } }, "en-us": { "role": { "label": "Finance income (cost)", "totalLabel": "Finance result, net" } } }, "localname": "FinanceIncomeCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities": { "auth_ref": [ "r137" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from finance income received, classified as operating activities. [Refer: Finance income]" } }, "en-us": { "role": { "label": "Finance income received, classified as operating activities", "terseLabel": "Interest income" } } }, "localname": "FinanceIncomeReceivedClassifiedAsOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssets": { "auth_ref": [ "r219", "r223", "r224", "r225", "r226" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } }, "en-us": { "role": { "label": "Financial assets" } } }, "localname": "FinancialAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsCategoryMember": { "auth_ref": [ "r229" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial assets, category [member]" } } }, "localname": "FinancialAssetsCategoryMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FinancialLiabilities": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } }, "en-us": { "role": { "label": "Financial liabilities" } } }, "localname": "FinancialLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialLiabilitiesCategoryMember": { "auth_ref": [ "r229" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]" } }, "en-us": { "role": { "label": "Financial liabilities, category [member]" } } }, "localname": "FinancialLiabilitiesCategoryMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_FixturesAndFittingsMember": { "auth_ref": [ "r54" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Furniture [Member]" } } }, "localname": "FixturesAndFittingsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ForeignExchangeRatesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Functional and reporting currency [Abstract]" } } }, "localname": "ForeignExchangeRatesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesFunctionalAndReportingCurrencyDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r76" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income", "terseLabel": "Re-measurement through other comprehensive income/(loss)" } } }, "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "auth_ref": [ "r43" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Currency translation differences" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "auth_ref": [ "r14", "r90" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 5.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Exchange differences", "terseLabel": "Loss in finance results, net" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails", "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossCarryingAmountMember": { "auth_ref": [ "r58", "r113", "r120", "r123", "r212", "r224", "r225", "r226", "r262", "r264" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } }, "en-us": { "role": { "label": "Acquisition Cost [Member]", "terseLabel": "Gross Carrying Amount [member]" } } }, "localname": "GrossCarryingAmountMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails", "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Income/(Loss) [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r41", "r46", "r47", "r48", "r100", "r157", "r240" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 }, "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Income tax expense", "negatedLabel": "Income tax expense", "totalLabel": "Effective income tax rate (benefit)/expense" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r139" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes", "terseLabel": "Net (decrease)/increase in cash and cash equivalents", "totalLabel": "Net (decrease)/increase in cash and cash equivalents" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInDeferredTaxLiabilityAsset": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in a deferred tax liability (asset). [Refer: Deferred tax liability (asset)]" } }, "en-us": { "role": { "label": "Increase in tax losses available as an offset" } } }, "localname": "IncreaseDecreaseInDeferredTaxLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Decrease/(increase) from actual defined benefit obligation" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": { "auth_ref": [ "r83" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption", "terseLabel": "Decrease/(increase) from actual defined benefit obligation" } } }, "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r80" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Increase (decrease) in net defined benefit liability (asset)", "totalLabel": "Net pension cost" } } }, "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": { "auth_ref": [ "r7" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments." } }, "en-us": { "role": { "label": "Conversion of note agreement, net of transaction costs", "terseLabel": "Conversion note agreement" } } }, "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "auth_ref": [ "r7" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } }, "en-us": { "role": { "label": "Increase (decrease) through exercise of options, equity", "terseLabel": "Exercise of options" } } }, "localname": "IncreaseDecreaseThroughExerciseOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r6" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "terseLabel": "Share-based payments" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": { "auth_ref": [ "r7" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]" } }, "en-us": { "role": { "label": "Held as treasury shares", "terseLabel": "Issuance of shares to be held as treasury shares, net of transaction costs" } } }, "localname": "IncreaseDecreaseThroughTreasuryShareTransactions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r16", "r115" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible asset", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "auth_ref": [ "r108", "r116", "r186" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill [member]" } } }, "localname": "IntangibleAssetsOtherThanGoodwillMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IntangibleAssetsCarryingAmountAndNetBookValueDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_InterestExpense": { "auth_ref": [ "r156", "r239", "r246" ], "calculation": { "http://acimume.com/role/ExpensesByCategoryDetails": { "order": 3.0, "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from interest." } }, "en-us": { "role": { "label": "Interest expense", "terseLabel": "Net interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "auth_ref": [ "r181" ], "calculation": { "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "aciu_ExpenseRelatingToLeases", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Interest expense on lease liabilities", "terseLabel": "Interest expense on lease liabilities" } } }, "localname": "InterestExpenseOnLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "auth_ref": [ "r137" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } }, "en-us": { "role": { "label": "Interest paid, classified as operating activities", "negatedLabel": "Interest paid" } } }, "localname": "InterestPaidClassifiedAsOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestRateRiskMember": { "auth_ref": [ "r237", "r254", "r255", "r256", "r257" ], "lang": { "en": { "role": { "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Interest rate risk [member]", "terseLabel": "Interest Rate [member]" } } }, "localname": "InterestRateRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r30" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Issued capital", "terseLabel": "Share capital" } } }, "localname": "IssuedCapital", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [member]", "terseLabel": "Share Capital [Member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r95" ], "calculation": { "http://acimume.com/role/RelatedpartyTransactionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "totalLabel": "Total" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "auth_ref": [ "r93" ], "calculation": { "http://acimume.com/role/RelatedpartyTransactionsDetails": { "order": 1.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Post-employment benefits" } } }, "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r94" ], "calculation": { "http://acimume.com/role/RelatedpartyTransactionsDetails": { "order": 2.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Share-based compensation" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "auth_ref": [ "r92" ], "calculation": { "http://acimume.com/role/RelatedpartyTransactionsDetails": { "order": 0.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Short-term employee benefits" } } }, "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RelatedpartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "auth_ref": [ "r97" ], "lang": { "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } }, "en-us": { "role": { "label": "Executives and Directors [Member]" } } }, "localname": "KeyManagementPersonnelOfEntityOrParentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFiveYearsMember": { "auth_ref": [ "r187", "r188", "r230", "r233", "r236", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than five years." } }, "en-us": { "role": { "label": "More Than 5 Years [Member]" } } }, "localname": "LaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "auth_ref": [ "r10", "r187", "r188", "r230", "r236", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } }, "en-us": { "role": { "label": "Later than four years and not later than five years [member]", "terseLabel": "Loss Expiry, December 31, 2028 [Member]" } } }, "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": { "auth_ref": [ "r230", "r231", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than three years." } }, "en-us": { "role": { "label": "Between 1 and 3 Years [Member]" } } }, "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "auth_ref": [ "r10", "r187", "r188", "r230", "r236", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } }, "en-us": { "role": { "label": "Later than one year and not later than two years [member]", "terseLabel": "Loss Expiry, December 31, 2025 [Member]", "verboseLabel": "Between 1 and 3 Years [Member]" } } }, "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": { "auth_ref": [ "r230", "r232", "r236" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than five years." } }, "en-us": { "role": { "label": "Between 3 and 5 Years [Member]" } } }, "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "auth_ref": [ "r10", "r187", "r188", "r230", "r236", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } }, "en-us": { "role": { "label": "Later than three years and not later than four years [member]", "terseLabel": "Loss Expiry, December 31, 2027 [Member]" } } }, "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "auth_ref": [ "r10", "r187", "r188", "r230", "r236", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } }, "en-us": { "role": { "label": "Later than two years and not later than three years [member]", "terseLabel": "Loss Expiry, December 31, 2026 [Member]", "verboseLabel": "Between 3 and 5 Years [Member]" } } }, "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LeaseLiabilitiesMember": { "auth_ref": [ "r138", "r142" ], "lang": { "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Lease liabilities [member]", "terseLabel": "Long-term Lease Liabilities [Member]" } } }, "localname": "LeaseLiabilitiesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_LeaseholdImprovementsMember": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } }, "en-us": { "role": { "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r21", "r158", "r159", "r160", "r241", "r245" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": { "auth_ref": [ "r71" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]" } }, "en-us": { "role": { "label": "Net defined benefit liability (asset)", "negatedPeriodEndLabel": "Defined benefit obligation, end of period", "negatedPeriodStartLabel": "Defined benefit obligation, beginning of period", "periodEndLabel": "Net defined benefit liabilities, end of period", "periodStartLabel": "Net defined benefit liabilities, beginning of period", "terseLabel": "Potential defined benefit obligation" } } }, "localname": "LiabilityAssetOfDefinedBenefitPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails", "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiquidityRiskMember": { "auth_ref": [ "r220", "r254", "r255", "r256" ], "lang": { "en": { "role": { "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]" } }, "en-us": { "role": { "label": "Liquidity risk [member]", "terseLabel": "Liquidity Risk [Member]" } } }, "localname": "LiquidityRiskMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income taxes [Abstract]", "terseLabel": "Income taxes [Abstract]" } } }, "localname": "MajorComponentsOfTaxExpenseIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MaturityAxis": { "auth_ref": [ "r24", "r85", "r174", "r187", "r188", "r218", "r227", "r230", "r250", "r251", "r253", "r259" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Maturity [axis]" } } }, "localname": "MaturityAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails", "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": { "auth_ref": [ "r71" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Net defined benefit liability (asset) [axis]" } } }, "localname": "NetDefinedBenefitLiabilityAssetAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NetDefinedBenefitLiabilityAssetMember": { "auth_ref": [ "r71" ], "lang": { "en": { "role": { "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Net defined benefit liability (asset) [member]" } } }, "localname": "NetDefinedBenefitLiabilityAssetMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentAssets": { "auth_ref": [ "r25", "r147", "r149" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } }, "en-us": { "role": { "label": "Non-current assets", "totalLabel": "Total non-current assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current assets [abstract]", "terseLabel": "Non-current assets" } } }, "localname": "NoncurrentAssetsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r179" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Long-term lease liabilities" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilities": { "auth_ref": [ "r26", "r147", "r151" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total non-current liabilities" } } }, "localname": "NoncurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-current liabilities [abstract]", "terseLabel": "Non-current liabilities" } } }, "localname": "NoncurrentLiabilitiesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": { "auth_ref": [ "r29" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]" } }, "en-us": { "role": { "label": "Non-current provisions for employee benefits", "terseLabel": "Net employee defined benefit liabilities" } } }, "localname": "NoncurrentProvisionsForEmployeeBenefits", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentRestrictedCashAndCashEquivalents": { "auth_ref": [ "r21" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]" } }, "en-us": { "role": { "label": "Non-current restricted cash and cash equivalents", "terseLabel": "Long-term financial assets" } } }, "localname": "NoncurrentRestrictedCashAndCashEquivalents", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NotLaterThanOneYearMember": { "auth_ref": [ "r23", "r187", "r188", "r230", "r236", "r259" ], "lang": { "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } }, "en-us": { "role": { "label": "Loss Expiry, December 31, 2024 [Member]", "terseLabel": "Within 1 Year [Member]", "verboseLabel": "2019 [Member]" } } }, "localname": "NotLaterThanOneYearMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails", "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable": { "auth_ref": [ "r209" ], "lang": { "en": { "role": { "documentation": "The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination." } }, "en-us": { "role": { "label": "Number of instruments or interests issued or issuable", "terseLabel": "Shares issued in acquisition" } } }, "localname": "NumberOfInstrumentsOrInterestsIssuedOrIssuable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "auth_ref": [ "r203", "r206" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments granted in share-based payment arrangement", "terseLabel": "Granted during the year (in shares)", "verboseLabel": "Number of non-vested share awards granted (in shares)" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments exercisable in share-based payment arrangement", "periodEndLabel": "Vested and exercisable (in shares)" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments exercised or vested in share-based payment arrangement", "negatedLabel": "Vested during the year" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments expired in share-based payment arrangement", "negatedLabel": "Expired during the year (in shares)" } } }, "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments forfeited in share-based payment arrangement", "negatedLabel": "Forfeited during the year (in shares)" } } }, "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments outstanding in share-based payment arrangement", "periodEndLabel": "Non-vested at end of period (in shares)", "periodStartLabel": "Non-vested at beginning of period (in shares)" } } }, "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOutstandingShareOptions": { "auth_ref": [ "r193", "r198", "r202" ], "lang": { "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Outstanding Options (in shares)", "periodEndLabel": "Outstanding at end of period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)" } } }, "localname": "NumberOfOutstandingShareOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r199" ], "lang": { "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercisable in share-based payment arrangement", "terseLabel": "Exercisable (in shares)" } } }, "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [ "r196" ], "lang": { "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercised in share-based payment arrangement", "negatedLabel": "Exercised during the year (in shares)" } } }, "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r197" ], "lang": { "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options expired in share-based payment arrangement", "negatedLabel": "Expired during the year (in shares)" } } }, "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "auth_ref": [ "r195" ], "lang": { "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options forfeited in share-based payment arrangement", "negatedLabel": "Forfeited during the year (in shares)" } } }, "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [ "r194" ], "lang": { "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Granted during the year (in shares)", "verboseLabel": "Number of options awarded (in shares)" } } }, "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r7" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued", "verboseLabel": "Shares issued (in shares)" } } }, "localname": "NumberOfSharesIssued", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesIssuedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Issuance of shares, net of transaction costs:" } } }, "localname": "NumberOfSharesIssuedAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r33" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "terseLabel": "Shares outstanding, excluding treasury shares (in shares)" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_OfficeEquipmentMember": { "auth_ref": [ "r55" ], "lang": { "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Office equipment [member]", "terseLabel": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OperatingExpense": { "auth_ref": [ "r42" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all operating expenses." } }, "en-us": { "role": { "label": "Operating expense", "negatedTotalLabel": "Total operating expenses" } } }, "localname": "OperatingExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OrdinarySharesMember": { "auth_ref": [ "r34", "r103" ], "lang": { "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } }, "en-us": { "role": { "label": "Ordinary shares [member]", "terseLabel": "Common Shares [Member]" } } }, "localname": "OrdinarySharesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherComprehensiveIncome": { "auth_ref": [ "r5", "r37", "r43", "r154" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } }, "en-us": { "role": { "label": "Other comprehensive income", "terseLabel": "Other comprehensive income/(loss)", "totalLabel": "Other comprehensive income/(loss)" } } }, "localname": "OtherComprehensiveIncome", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "auth_ref": [ "r27", "r43", "r67" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0 }, "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } }, "en-us": { "role": { "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans", "negatedTotalLabel": "Total other comprehensive gain/(loss)", "terseLabel": "Re-measurement gains/(losses) on defined-benefit plans" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentLiabilities": { "auth_ref": [ "r21" ], "calculation": { "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails": { "order": 5.0, "parentTag": "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Other current liabilities", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherCurrentLiabilities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherCurrentReceivables": { "auth_ref": [ "r28" ], "calculation": { "http://acimume.com/role/OtherCurrentReceivablesDetails": { "order": 3.0, "parentTag": "aciu_CurrentReceivablesClassifiedAsOtherAndValueAddedAndWithholdingTaxes", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } }, "en-us": { "role": { "label": "Other current receivables", "terseLabel": "Other current receivables" } } }, "localname": "OtherCurrentReceivables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherMaterialActuarialAssumptions": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "Any other material assumption used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]" } }, "en-us": { "role": { "label": "Other material actuarial assumptions", "terseLabel": "Interest rate on retirement savings capital" } } }, "localname": "OtherMaterialActuarialAssumptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_OtherMaterialActuarialAssumptionsMember": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "This member stands for material actuarial assumptions that the entity does not separately disclose in the same statement or note. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Other material actuarial assumptions [member]", "terseLabel": "Interest Rate on Savings Capital [Member]" } } }, "localname": "OtherMaterialActuarialAssumptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherOperatingIncomeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_OperatingExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other operating income/(expense)" } } }, "localname": "OtherOperatingIncomeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherTangibleOrIntangibleAssetsTransferred": { "auth_ref": [ "r208" ], "calculation": { "http://acimume.com/role/AssetAcquisitionDetails": { "order": 1.0, "parentTag": "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value, at acquisition date, of other tangible or intangible assets (including a business or subsidiary of the acquirer) transferred as consideration in a business combination, that the entity does not separately disclose in the same note. [Refer: Intangible assets other than goodwill; Business combinations [member]; Subsidiaries [member]]" } }, "en-us": { "role": { "label": "IPR&D Asset" } } }, "localname": "OtherTangibleOrIntangibleAssetsTransferred", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/AssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ParValuePerShare": { "auth_ref": [ "r32" ], "lang": { "en": { "role": { "documentation": "The nominal value per share." } }, "en-us": { "role": { "label": "Par value per share", "terseLabel": "Nominal value per share (in CHF per share)" } } }, "localname": "ParValuePerShare", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails", "http://acimume.com/role/ShareCapitalCapitalStructureDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r77" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "s" } }, "en-us": { "role": { "label": "Increase (decrease) in net defined benefit liability (asset) resulting from past service cost and losses (gains) arising from settlements", "verboseLabel": "Net pension cost through statement of income/(loss)" } } }, "localname": "PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInNetDefinedBenefitLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsForShareIssueCosts": { "auth_ref": [ "r130" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for share issue costs." } }, "en-us": { "role": { "label": "Payments for share issue costs", "negatedLabel": "Transaction costs on issuance of shares" } } }, "localname": "PaymentsForShareIssueCosts", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r79" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]" } }, "en-us": { "role": { "label": "Decrease (increase) in net defined benefit liability (asset) resulting from payments from plan", "terseLabel": "Benefits deposited", "verboseLabel": "Benefits deposited" } } }, "localname": "PaymentsFromPlanNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "auth_ref": [ "r129" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Principal payments of lease obligations" } } }, "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "auth_ref": [ "r127" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } }, "en-us": { "role": { "label": "Payments to acquire or redeem entity's shares", "negatedLabel": "Payment for the issuance of treasury shares" } } }, "localname": "PaymentsToAcquireOrRedeemEntitysShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfEntitysRevenue": { "auth_ref": [ "r249" ], "lang": { "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Percentage of entity's revenue", "terseLabel": "Percentage of contract revenues" } } }, "localname": "PercentageOfEntitysRevenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption": { "auth_ref": [ "r83" ], "lang": { "en": { "role": { "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Percentage of reasonably possible decrease in actuarial assumption", "terseLabel": "Percentage decrease in actuarial assumption" } } }, "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumption", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": { "auth_ref": [ "r83" ], "lang": { "en": { "role": { "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [member]]" } }, "en-us": { "role": { "label": "Percentage of reasonably possible increase in actuarial assumption", "terseLabel": "Percentage increase in actuarial assumption" } } }, "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PerformanceObligationsAxis": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Performance obligations [axis]" } } }, "localname": "PerformanceObligationsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_PerformanceObligationsMember": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "This member stands for all performance obligations. A performance obligation is a promise in a contract with a customer to transfer to the customer either: (a) a good or service (or a bundle of goods or services) that is distinct; or (b) a series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer. This member also represents the standard value for the 'Performance obligations' axis if no other member is used." } }, "en-us": { "role": { "label": "Performance obligations [member]" } } }, "localname": "PerformanceObligationsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_PlanAssetsAtFairValue": { "auth_ref": [ "r88" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": 1.0, "parentTag": "ifrs-full_SurplusDeficitInPlan", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "Plan assets, at fair value", "periodEndLabel": "Fair value of plan assets, end of period", "periodStartLabel": "Fair value of plan assets, beginning of period", "terseLabel": "Fair value of plan assets" } } }, "localname": "PlanAssetsAtFairValue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PlanAssetsMember": { "auth_ref": [ "r69" ], "lang": { "en": { "role": { "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies." } }, "en-us": { "role": { "label": "Plan assets [member]", "terseLabel": "Fair Value of Plan Assets [Member]" } } }, "localname": "PlanAssetsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": { "auth_ref": [ "r87" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods." } }, "en-us": { "role": { "label": "Expected contribution by employer to be paid to post-retirement benefit plans" } } }, "localname": "PostemploymentBenefitExpenseDefinedContributionPlans", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PresentValueOfDefinedBenefitObligationMember": { "auth_ref": [ "r70" ], "lang": { "en": { "role": { "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods." } }, "en-us": { "role": { "label": "Present value of defined benefit obligation [member]", "terseLabel": "Defined Benefit Obligation [Member]" } } }, "localname": "PresentValueOfDefinedBenefitObligationMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangesInDefinedBenefitObligationDetails", "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_PresentationOfLeasesForLesseeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right-of-use assets and lease liabilities [Abstract]" } } }, "localname": "PresentationOfLeasesForLesseeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r128" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Proceeds from long-term financing obligation" } } }, "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfOptions": { "auth_ref": [ "r130" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of options." } }, "en-us": { "role": { "label": "Proceeds from exercise of options", "terseLabel": "Proceeds from issuance of common shares - option plan, net of transaction costs" } } }, "localname": "ProceedsFromExerciseOfOptions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "auth_ref": [ "r130" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } }, "en-us": { "role": { "label": "Proceeds from issue of ordinary shares", "terseLabel": "Proceeds from issuance of common shares - asset acquisition, net of transaction costs" } } }, "localname": "ProceedsFromIssueOfOrdinaryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares": { "auth_ref": [ "r130" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]" } }, "en-us": { "role": { "label": "Proceeds from sale or issue of treasury shares", "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs", "verboseLabel": "Proceeds from sale of treasury shares, net of underwriting fees and transaction costs" } } }, "localname": "ProceedsFromSaleOrIssueOfTreasuryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows", "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r126" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment, classified as investing activities", "terseLabel": "Proceeds from sale of property, plant and equipment" } } }, "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r175", "r247" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r175", "r247" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } }, "en-us": { "role": { "label": "Products and services [member]" } } }, "localname": "ProductsAndServicesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r4", "r36", "r131", "r144", "r146", "r147", "r241", "r243", "r252", "r261" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0 }, "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 }, "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Income/(loss) for the period", "terseLabel": "Net income/(loss) for the period", "totalLabel": "Income/(loss) for the period", "verboseLabel": "Net income/(loss) attributable to equity holders of the Company" } } }, "localname": "ProfitLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows", "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss", "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity [abstract]", "verboseLabel": "Numerator [Abstract]" } } }, "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r1", "r2", "r216", "r241", "r243" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Income/(loss) before income tax", "totalLabel": "Income/(loss) before tax" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromOperatingActivities": { "auth_ref": [ "r42", "r102" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from operating activities", "totalLabel": "Operating income/(loss)" } } }, "localname": "ProfitLossFromOperatingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r15", "r62" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment", "periodEndLabel": "Property, plant and equipment, end of period", "periodStartLabel": "Property, plant and equipment, beginning of period" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipmentMember": { "auth_ref": [ "r63", "r108", "r186" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Property, plant and equipment [member]" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails", "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesRightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Provisions": { "auth_ref": [ "r19" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits." } }, "en-us": { "role": { "label": "Provisions", "terseLabel": "Commitments" } } }, "localname": "Provisions", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r125" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchases of property, plant and equipment" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r162", "r163", "r164", "r202", "r228", "r253" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails", "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/OtherCurrentReceivablesDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r162", "r163", "r164", "r202", "r228", "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } }, "en-us": { "role": { "label": "Ranges [member]" } } }, "localname": "RangesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails", "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/OtherCurrentReceivablesDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "auth_ref": [ "r202" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "auth_ref": [ "r202" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [member]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ReceivablesFromContractsWithCustomers": { "auth_ref": [ "r165", "r168" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of an entity\u2019s right to consideration in exchange for goods or services that the entity has transferred to a customer that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due." } }, "en-us": { "role": { "label": "Receivables from contracts with customers", "terseLabel": "Milestone payment receivable", "verboseLabel": "Eligible grant amount receivable" } } }, "localname": "ReceivablesFromContractsWithCustomers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of accounting profit multiplied by applicable tax rates [abstract]", "terseLabel": "Income tax expense reconciled to Income / (loss) [Abstract]" } } }, "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of changes in property, plant and equipment [abstract]", "terseLabel": "Property, plant and equipment [Abstract]" } } }, "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/PropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RepaymentsOfCurrentBorrowings": { "auth_ref": [ "r130" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]" } }, "en-us": { "role": { "label": "Repayments of current borrowings", "negatedLabel": "Repayment of short-term financing obligation" } } }, "localname": "RepaymentsOfCurrentBorrowings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r117" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 1.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development expense", "negatedLabel": "Research & development expenses", "totalLabel": "Total research and development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r30", "r44" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings", "terseLabel": "Accumulated losses" } } }, "localname": "RetainedEarnings", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r8", "r9" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings [member]", "terseLabel": "Accumulated Losses [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "domainItemType" }, "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": { "auth_ref": [ "r73" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails": { "order": 3.0, "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]" } }, "en-us": { "role": { "label": "Return on plan assets excluding interest income", "terseLabel": "Return on plan assets excluding interest income" } } }, "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails", "http://acimume.com/role/RetirementBenefitPlanChangesInFairValueOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r1", "r2", "r39", "r147", "r153", "r216", "r238", "r242", "r247", "r248", "r249" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenue", "totalLabel": "Total revenue" } } }, "localname": "Revenue", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract revenues [Abstract]", "terseLabel": "Revenues" } } }, "localname": "RevenueAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_RevenueFromContractsWithCustomers": { "auth_ref": [ "r166", "r167" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 0.0, "parentTag": "ifrs-full_Revenue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } }, "en-us": { "role": { "label": "Recognized revenues", "terseLabel": "Contract revenue", "verboseLabel": "Total contract revenue" } } }, "localname": "RevenueFromContractsWithCustomers", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods": { "auth_ref": [ "r170" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue from performance obligations satisfied (or partially satisfied) in previous periods. [Refer: Performance obligations [member]; Revenue from contracts with customers]" } }, "en-us": { "role": { "label": "Performance obligations satisfied in previous periods" } } }, "localname": "RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesRecognizedRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": { "auth_ref": [ "r169" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue that was included in the contract liability balance at the beginning of the period. [Refer: Contract liabilities; Revenue from contracts with customers]" } }, "en-us": { "role": { "label": "Amounts included in the contract liability at the beginning of the period" } } }, "localname": "RevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesRecognizedRevenuesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r185" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "RightofuseAssets", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SaleOrIssueOfTreasuryShares": { "auth_ref": [ "r7" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase in equity resulting from the sale or issue of treasury shares. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Sale or issue of treasury shares", "terseLabel": "Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs" } } }, "localname": "SaleOrIssueOfTreasuryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss": { "order": 2.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://acimume.com/role/ExpensesByCategoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } }, "en-us": { "role": { "label": "Selling, general and administrative expense", "negatedLabel": "General & administrative expenses", "totalLabel": "Total general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfIncomeLoss", "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense [abstract]", "terseLabel": "General and administrative [Abstract]" } } }, "localname": "SellingGeneralAndAdministrativeExpenseAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ExpensesByCategoryDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ShareIssueRelatedCost": { "auth_ref": [ "r7" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } }, "en-us": { "role": { "label": "Transaction costs associated with issuance of shares in relation to the asset acquisition recorded in Accrued expenses", "terseLabel": "Issuance costs" } } }, "localname": "ShareIssueRelatedCost", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfCashFlows", "http://acimume.com/role/ShareCapitalAtMarketEquityOfferingDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharePremium": { "auth_ref": [ "r30" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value." } }, "en-us": { "role": { "label": "Share premium" } } }, "localname": "SharePremium", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharePremiumMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } }, "en-us": { "role": { "label": "Share Premium [Member]" } } }, "localname": "SharePremiumMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_SharebasedPaymentArrangementsMember": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } }, "en-us": { "role": { "label": "Share-based payment arrangements [member]" } } }, "localname": "SharebasedPaymentArrangementsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ShorttermEmployeeBenefitsAccruals": { "auth_ref": [ "r31" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]" } }, "en-us": { "role": { "label": "Short-term employee benefits accruals", "terseLabel": "Accrual of performance-related remuneration" } } }, "localname": "ShorttermEmployeeBenefitsAccruals", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Changes in Equity [Abstract]" } } }, "localname": "StatementOfChangesInEquityAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Statement of changes in equity [line items]" } } }, "localname": "StatementOfChangesInEquityLineItems", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Comprehensive Income/(Loss) [Abstract]" } } }, "localname": "StatementOfComprehensiveIncomeAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_SurplusDeficitInPlan": { "auth_ref": [ "r88" ], "calculation": { "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]" } }, "en-us": { "role": { "label": "Surplus (deficit) in plan", "totalLabel": "Total liability" } } }, "localname": "SurplusDeficitInPlan", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SurplusDeficitInPlanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Surplus (deficit) in plan [abstract]", "terseLabel": "Defined benefit pension plan amount recognized in balance sheet [Abstract]" } } }, "localname": "SurplusDeficitInPlanAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanSummaryOfBenefitPlanDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "auth_ref": [ "r47" ], "calculation": { "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails": { "order": 3.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)", "terseLabel": "(Income not subject to tax)/expenses not deductible for tax purposes" } } }, "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfRevenuesExemptFromTaxation2011": { "auth_ref": [ "r47" ], "calculation": { "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails": { "order": 4.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to revenues that are exempt from taxation. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of revenues exempt from taxation", "negatedLabel": "(Income not subject to tax)/expenses not deductible for tax purposes" } } }, "localname": "TaxEffectOfRevenuesExemptFromTaxation2011", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxEffectOfTaxLosses": { "auth_ref": [ "r47" ], "calculation": { "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails": { "order": 6.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } }, "en-us": { "role": { "label": "Tax effect of tax losses", "terseLabel": "Effect of unused tax losses and tax offsets not recognized as deferred tax assets" } } }, "localname": "TaxEffectOfTaxLosses", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "auth_ref": [ "r47" ], "calculation": { "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails": { "order": 0.0, "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } }, "en-us": { "role": { "label": "Tax (benefit)/expense calculated at the domestic rates applicable in the respective countries" } } }, "localname": "TaxExpenseIncomeAtApplicableTaxRate", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } } }, "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [member]" } } }, "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r162", "r163", "r164", "r202", "r228", "r253" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top of range [member]", "terseLabel": "Top of Range [Member]" } } }, "localname": "TopOfRangeMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails", "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://acimume.com/role/IncomeTaxesSummaryOfIncomeTaxExpenseDetails", "http://acimume.com/role/OtherCurrentReceivablesDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForBondsAndSimilarDebtInstrumentsDetails", "http://acimume.com/role/ShareCapitalConditionalShareCapitalForEmployeeBenefitPlansDetails", "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r18" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Trade and other payables", "verboseLabel": "Total trade and other payables" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets", "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentPayablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other payables and accrued expenses [Abstract]" } } }, "localname": "TradeAndOtherCurrentPayablesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TradeAndOtherReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and other receivables [abstract]", "terseLabel": "Other current receivables [abstract]" } } }, "localname": "TradeAndOtherReceivablesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/OtherCurrentReceivablesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": { "auth_ref": [ "r173" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]" } }, "en-us": { "role": { "label": "Transaction price allocated to remaining performance obligations", "terseLabel": "Total potential collaboration agreement value remaining", "verboseLabel": "Expected transaction price allocation" } } }, "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TreasuryShares": { "auth_ref": [ "r30", "r101" ], "calculation": { "http://acimume.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "ifrs-full_Equity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } }, "en-us": { "role": { "label": "Treasury shares", "negatedLabel": "Treasury shares" } } }, "localname": "TreasuryShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TreasurySharesMember": { "auth_ref": [ "r8" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } }, "en-us": { "role": { "label": "Treasury shares [member]", "terseLabel": "Treasury Shares [Member]" } } }, "localname": "TreasurySharesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ConsolidatedStatementsOfChangesInEquity", "http://acimume.com/role/ShareCapitalCapitalStructureDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfContractsAxis": { "auth_ref": [ "r176", "r260" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of contracts [axis]" } } }, "localname": "TypesOfContractsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails", "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails", "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfContractsMember": { "auth_ref": [ "r176", "r260" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } }, "en-us": { "role": { "label": "Types of contracts [member]" } } }, "localname": "TypesOfContractsMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/ContractRevenuesAntiabetaAntibodyInAd2006AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAntitauAntibodyInAd2012AgreementWithGenentechDetails", "http://acimume.com/role/ContractRevenuesAsynAndTdp43PetTracers2016AgreementWithBiogenDetails", "http://acimume.com/role/ContractRevenuesContractRevenueAttributableToLicensingArrangementsDetails", "http://acimume.com/role/ContractRevenuesGrantFromTargetAlsFoundationDetails", "http://acimume.com/role/ContractRevenuesGrantsFromMichaelJFoxFoundationDetails", "http://acimume.com/role/ContractRevenuesMorphomerTauSmallMolecule2018LicenseAgreementWithEliLillyAndCompanyDetails", "http://acimume.com/role/ContractRevenuesTauVaccineInAd2014AgreementWithJanssenPharmaceuticalsDetails", "http://acimume.com/role/ContractRevenuesTaupetImagingAgent2014AgreementWithLifeMolecularImagingFormerlyPiramalImagingSaDetails", "http://acimume.com/role/PrepaidExpensesAndAccruedIncomeDetails", "http://acimume.com/role/TradeAndOtherPayablesAndAccruedExpensesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfRisksAxis": { "auth_ref": [ "r217", "r221", "r222", "r254", "r255", "r256", "r258" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of risks [axis]" } } }, "localname": "TypesOfRisksAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_TypesOfRisksMember": { "auth_ref": [ "r217", "r221", "r222", "r254", "r255", "r256", "r258" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } }, "en-us": { "role": { "label": "Risks [member]" } } }, "localname": "TypesOfRisksMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/FinancialInstrumentsAndRiskManagementDetails", "http://acimume.com/role/RetirementBenefitPlanActuarialAssumptionsAndSensitivityAnalysisDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } } }, "localname": "TypesOfSharebasedPaymentArrangementsAxis", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails", "http://acimume.com/role/SharebasedCompensationPlansOutstandingDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": { "auth_ref": [ "r49" ], "lang": { "en": { "role": { "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]" } }, "en-us": { "role": { "label": "Unused tax losses for which no deferred tax asset recognised", "terseLabel": "Unrecorded tax loss carryforwards" } } }, "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_UnusedTaxLossesMember": { "auth_ref": [ "r51" ], "lang": { "en": { "role": { "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit." } }, "en-us": { "role": { "label": "Unused tax losses [member]", "terseLabel": "Tax Losses [Member]" } } }, "localname": "UnusedTaxLossesMember", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/IncomeTaxesUnrecognizedDeductibleTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCreditsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": { "auth_ref": [ "r57" ], "lang": { "en": { "role": { "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Useful life measured as period of time, property, plant and equipment", "terseLabel": "Estimated useful life" } } }, "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019": { "auth_ref": [ "r85" ], "lang": { "en": { "role": { "documentation": "The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average duration period for defined benefit obligation" } } }, "localname": "WeightedAverageDurationOfDefinedBenefitObligation2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RetirementBenefitPlanChangeInOtherComprehensiveLossDetails" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments exercisable in share-based payment arrangement", "periodEndLabel": "Vested and exercisable (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement", "terseLabel": "Vested during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments expired in share-based payment arrangement", "terseLabel": "Expired during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement", "terseLabel": "Forfeited during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement", "terseLabel": "Granted during the year (in CHF per share)", "verboseLabel": "Weighted average fair value, restricted share awards granted (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r203" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement", "periodEndLabel": "Non-vested at end of period (in CHF per share)", "periodStartLabel": "Non-vested at beginning of period (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationNonvestedShareAwardsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "auth_ref": [ "r199" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement", "terseLabel": "Exercisable (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r196" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Exercised during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r197" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Expired during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r195" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Forfeited during the year (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r194" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Granted during the year (in CHF per share)", "terseLabel": "Weighted average exercise price for options granted (in CHF/USD per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails", "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": { "auth_ref": [ "r201" ], "lang": { "en": { "role": { "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Share-based payment arrangements [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise", "terseLabel": "Weighted average share price of common share options exercised (in dollars per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationOutstandingOptionsRangeOfExercisePricesAndExpirationDatesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r193", "r198" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Outstanding at end of period (in CHF per share)", "periodStartLabel": "Outstanding at beginning of period (in CHF per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": { "auth_ref": [ "r189" ], "lang": { "en": { "role": { "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment." } }, "en-us": { "role": { "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16", "terseLabel": "Weighted average incremental borrowing rate" } } }, "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/RightofuseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "auth_ref": [ "r202" ], "lang": { "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options", "terseLabel": "Weighted average remaining term (years)" } } }, "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageExercisePricesDetails" ], "xbrltype": "durationItemType" }, "ifrs-full_WeightedAverageSharePrice2019": { "auth_ref": [ "r201" ], "lang": { "en": { "role": { "documentation": "The weighted average share price. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price", "verboseLabel": "Share price, weighted average (in USD per share)" } } }, "localname": "WeightedAverageSharePrice2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "auth_ref": [ "r204" ], "lang": { "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average share price, share options granted", "terseLabel": "Weighted average fair value, options granted (in USD/CHF per share)" } } }, "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/SharebasedCompensationWeightedAverageGrantDateFairValueAndAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating basic earnings per share", "terseLabel": "Weighted-average number of shares outstanding to equity holders (in shares)" } } }, "localname": "WeightedAverageShares", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]", "verboseLabel": "Denominator [Abstract]" } } }, "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full", "presentation": [ "http://acimume.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://acimume.com/role/CashAndCashEquivalentsAndFinancialAssetsCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 24 } }, "std_ref": { "r0": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2021-03-24" }, "r1": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard", "URIDate": "2021-03-24" }, "r10": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2021-03-24" }, "r100": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2021-03-24" }, "r101": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "32", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r102": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "32", "Paragraph": "IE33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r103": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r104": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard", "URIDate": "2021-03-24" }, "r105": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2021-03-24" }, "r106": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "33", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2021-03-24" }, "r107": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r108": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r109": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r11": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard", "URIDate": "2021-03-24" }, "r110": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_v&doctype=Standard", "URIDate": "2021-03-24" }, "r111": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_e_v&doctype=Standard", "URIDate": "2021-03-24" }, "r112": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "37", "Paragraph": "86", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86&doctype=Standard", "URIDate": "2021-03-24" }, "r113": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2021-03-24" }, "r114": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r115": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2021-03-24" }, "r116": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "118", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard", "URIDate": "2021-03-24" }, "r117": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard", "URIDate": "2021-03-24" }, "r118": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "38", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2021-03-24" }, "r119": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "76", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard", "URIDate": "2021-03-24" }, "r12": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "117", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard", "URIDate": "2021-03-24" }, "r120": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2021-03-24" }, "r121": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "40", "Paragraph": "79", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2021-03-24" }, "r122": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "50", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard", "URIDate": "2021-03-24" }, "r123": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "41", "Paragraph": "54", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2021-03-24" }, "r124": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard", "URIDate": "2021-03-24" }, "r125": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2021-03-24" }, "r126": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2021-03-24" }, "r127": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r128": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2021-03-24" }, "r129": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r13": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "134", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_134&doctype=Standard", "URIDate": "2021-03-24" }, "r130": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r131": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2021-03-24" }, "r132": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2021-03-24" }, "r133": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2021-03-24" }, "r134": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard", "URIDate": "2021-03-24" }, "r135": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r136": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard", "URIDate": "2021-03-24" }, "r137": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "31", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard", "URIDate": "2021-03-24" }, "r138": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "44C", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2021-03-24" }, "r139": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r14": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard", "URIDate": "2021-03-24" }, "r140": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2021-03-24" }, "r141": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI", "URIDate": "2021-03-24" }, "r142": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "7", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI", "URIDate": "2021-03-24" }, "r143": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2021-03-24" }, "r144": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2021-03-24" }, "r145": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r146": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r147": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r148": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r149": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r15": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2021-03-24" }, "r150": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r151": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r152": { "Clause": "ix", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r153": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r154": { "Clause": "viii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r155": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r156": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r157": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r158": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2021-03-24" }, "r159": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2021-03-24" }, "r16": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2021-03-24" }, "r160": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2021-03-24" }, "r161": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "93", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard", "URIDate": "2021-03-24" }, "r162": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r163": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2021-03-24" }, "r164": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2021-03-24" }, "r165": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "105", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_105&doctype=Standard", "URIDate": "2021-03-24" }, "r166": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "113", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2021-03-24" }, "r167": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "114", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard", "URIDate": "2021-03-24" }, "r168": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "116", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_a&doctype=Standard", "URIDate": "2021-03-24" }, "r169": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "116", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_b&doctype=Standard", "URIDate": "2021-03-24" }, "r17": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2021-03-24" }, "r170": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "116", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_c&doctype=Standard", "URIDate": "2021-03-24" }, "r171": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "118", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard", "URIDate": "2021-03-24" }, "r172": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "119", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard", "URIDate": "2021-03-24" }, "r173": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_a&doctype=Standard", "URIDate": "2021-03-24" }, "r174": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "120", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r175": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r176": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r177": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI", "URIDate": "2021-03-24" }, "r178": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "15", "Section": "Presentation", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI", "URIDate": "2021-03-24" }, "r179": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r18": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2021-03-24" }, "r180": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2021-03-24" }, "r181": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2021-03-24" }, "r182": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_c&doctype=Standard", "URIDate": "2021-03-24" }, "r183": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard", "URIDate": "2021-03-24" }, "r184": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2021-03-24" }, "r185": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2021-03-24" }, "r186": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r187": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "94", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard", "URIDate": "2021-03-24" }, "r188": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "97", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard", "URIDate": "2021-03-24" }, "r189": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Paragraph": "C12", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C", "URIDate": "2021-03-24" }, "r19": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "l", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_l&doctype=Standard", "URIDate": "2021-03-24" }, "r190": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2021-03-24" }, "r191": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "16", "Section": "Presentation", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2021-03-24" }, "r192": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "44", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard", "URIDate": "2021-03-24" }, "r193": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r194": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r195": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r196": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r197": { "Clause": "v", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2021-03-24" }, "r198": { "Clause": "vi", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2021-03-24" }, "r199": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r2": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard", "URIDate": "2021-03-24" }, "r20": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "o", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2021-03-24" }, "r200": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2021-03-24" }, "r201": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard", "URIDate": "2021-03-24" }, "r202": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2021-03-24" }, "r203": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard", "URIDate": "2021-03-24" }, "r204": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r205": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2021-03-24" }, "r206": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2021-03-24" }, "r207": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r208": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_ii&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r209": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r21": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard", "URIDate": "2021-03-24" }, "r210": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r211": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r212": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r213": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r214": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI", "URIDate": "2021-03-24" }, "r215": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "3", "Section": "Disclosures application of paragraphs 59 and 61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI", "URIDate": "2021-03-24" }, "r216": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2021-03-24" }, "r217": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "21C", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2021-03-24" }, "r218": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "23B", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2021-03-24" }, "r219": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "25", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard", "URIDate": "2021-03-24" }, "r22": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "56", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard", "URIDate": "2021-03-24" }, "r220": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r221": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "33", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard", "URIDate": "2021-03-24" }, "r222": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r223": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35H", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2021-03-24" }, "r224": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35I", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2021-03-24" }, "r225": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35M", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2021-03-24" }, "r226": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "35N", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2021-03-24" }, "r227": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "42E", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2021-03-24" }, "r228": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r229": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "8", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_8&doctype=Standard", "URIDate": "2021-03-24" }, "r23": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2021-03-24" }, "r230": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B11", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r231": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r232": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r233": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r234": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B35", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r235": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "B52", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2021-03-24" }, "r236": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Paragraph": "IG31A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r237": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "7", "Section": "Defined terms", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2021-03-24" }, "r238": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2021-03-24" }, "r239": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2021-03-24" }, "r24": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "61", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard", "URIDate": "2021-03-24" }, "r240": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2021-03-24" }, "r241": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard", "URIDate": "2021-03-24" }, "r242": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2021-03-24" }, "r243": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2021-03-24" }, "r244": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2021-03-24" }, "r245": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2021-03-24" }, "r246": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2021-03-24" }, "r247": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard", "URIDate": "2021-03-24" }, "r248": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2021-03-24" }, "r249": { "IssueDate": "2021-01-01", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard", "URIDate": "2021-03-24" }, "r25": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard", "URIDate": "2021-03-24" }, "r250": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard", "URIDate": "2021-03-24" }, "r251": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "109A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2021-03-24" }, "r252": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2021-03-24" }, "r253": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard", "URIDate": "2021-03-24" }, "r254": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "124", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard", "URIDate": "2021-03-24" }, "r255": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "125", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard", "URIDate": "2021-03-24" }, "r256": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "127", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard", "URIDate": "2021-03-24" }, "r257": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r258": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "128", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2021-03-24" }, "r259": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "132", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2021-03-24" }, "r26": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard", "URIDate": "2021-03-24" }, "r260": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2021-03-24" }, "r261": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2021-03-24" }, "r262": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "37", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b", "URIDate": "2021-03-24" }, "r263": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r264": { "IssueDate": "2021-01-01", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "7", "Paragraph": "IG29", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b", "URIDate": "2021-03-24" }, "r265": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r266": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r267": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r268": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r269": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r27": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "7", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard", "URIDate": "2021-03-24" }, "r270": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r271": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r272": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r273": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r274": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r28": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2021-03-24" }, "r29": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2021-03-24" }, "r3": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2021-03-24" }, "r30": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2021-03-24" }, "r31": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "78", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard", "URIDate": "2021-03-24" }, "r32": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r33": { "Clause": "iv", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2021-03-24" }, "r34": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2021-03-24" }, "r35": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "79", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard", "URIDate": "2021-03-24" }, "r36": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2021-03-24" }, "r37": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2021-03-24" }, "r38": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2021-03-24" }, "r39": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2021-03-24" }, "r4": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2021-03-24" }, "r40": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2021-03-24" }, "r41": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2021-03-24" }, "r42": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard", "URIDate": "2021-03-24" }, "r43": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2021-03-24" }, "r44": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2021-03-24" }, "r45": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "10", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2021-03-24" }, "r46": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard", "URIDate": "2021-03-24" }, "r47": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r48": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r49": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2021-03-24" }, "r5": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r50": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2021-03-24" }, "r51": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2021-03-24" }, "r52": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Paragraph": "81", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81&doctype=Standard", "URIDate": "2021-03-24" }, "r53": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "12", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2021-03-24" }, "r54": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2021-03-24" }, "r55": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "Subparagraph": "h", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2021-03-24" }, "r56": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "37", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard", "URIDate": "2021-03-24" }, "r57": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2021-03-24" }, "r58": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2021-03-24" }, "r59": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2021-03-24" }, "r6": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r60": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r61": { "Clause": "vii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2021-03-24" }, "r62": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2021-03-24" }, "r63": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "73", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard", "URIDate": "2021-03-24" }, "r64": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2021-03-24" }, "r65": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Paragraph": "75", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2021-03-24" }, "r66": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "16", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2021-03-24" }, "r67": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "135", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2021-03-24" }, "r68": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "138", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138&doctype=Standard", "URIDate": "2021-03-24" }, "r69": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "140", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_i&doctype=Standard", "URIDate": "2021-03-24" }, "r7": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2021-03-24" }, "r70": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "140", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r71": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "140", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_140_a&doctype=Standard", "URIDate": "2021-03-24" }, "r72": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_a&doctype=Standard", "URIDate": "2021-03-24" }, "r73": { "Clause": "i", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_i&doctype=Standard", "URIDate": "2021-03-24" }, "r74": { "Clause": "ii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_ii&doctype=Standard", "URIDate": "2021-03-24" }, "r75": { "Clause": "iii", "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c_iii&doctype=Standard", "URIDate": "2021-03-24" }, "r76": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_c&doctype=Standard", "URIDate": "2021-03-24" }, "r77": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "d", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_d&doctype=Standard", "URIDate": "2021-03-24" }, "r78": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_f&doctype=Standard", "URIDate": "2021-03-24" }, "r79": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "Subparagraph": "g", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_g&doctype=Standard", "URIDate": "2021-03-24" }, "r8": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard", "URIDate": "2021-03-24" }, "r80": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "141", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141&doctype=Standard", "URIDate": "2021-03-24" }, "r81": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "142", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard", "URIDate": "2021-03-24" }, "r82": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "144", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard", "URIDate": "2021-03-24" }, "r83": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "145", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145_a&doctype=Standard", "URIDate": "2021-03-24" }, "r84": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "145", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_145&doctype=Standard", "URIDate": "2021-03-24" }, "r85": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "147", "Subparagraph": "c", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2021-03-24" }, "r86": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "149", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_149&doctype=Standard", "URIDate": "2021-03-24" }, "r87": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "53", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard", "URIDate": "2021-03-24" }, "r88": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Paragraph": "57", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2021-03-24" }, "r89": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "19", "Section": "Scope", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2021-03-24" }, "r9": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard", "URIDate": "2021-03-24" }, "r90": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "21", "Paragraph": "52", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2021-03-24" }, "r91": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "21", "Section": "Disclosure", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI", "URIDate": "2021-03-24" }, "r92": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "a", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2021-03-24" }, "r93": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "b", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2021-03-24" }, "r94": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2021-03-24" }, "r95": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard", "URIDate": "2021-03-24" }, "r96": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "18A", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18A&doctype=Standard", "URIDate": "2021-03-24" }, "r97": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "Subparagraph": "f", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2021-03-24" }, "r98": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard", "URIDate": "2021-03-24" }, "r99": { "IssueDate": "2021-01-01", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2021-03-24" } }, "version": "2.1" }